ENGINEERED MICROORGANISMS FOR THE DECONSTRUCTION OF POLYMERS

Abstract

Disclosed herein are methods and compositions for catalytic glycolysis to deconstruct PET to bis(2-hydroxyethyl) terephthalate (BHET). For BHET conversion to terephthalate and ethylene glycol, we engineer Pseudomonas putida KT2440 with PETase and MHETase enzymes from Ideonella sakaiensis. We further engineer P. putida to convert terephthalate to a performance-advantaged bioproduct, β-ketoadipic acid, and for improved utilization of ethylene glycol, a byproduct of BHET catabolism. In a bioreactor, we produce 15.1±0.6 g/L of β-ketoadipic acid (βKA) from BHET at 76±3% molar yield. Lastly, we demonstrate conversion of catalytically depolymerized PET to βKA. Overall, this work highlights the potential of tandem catalytic deconstruction and biological conversion as a means to upcycle waste PET.

Description

SEQUENCE LISTING

The instant application contains a Sequence Listing which has been submitted via EFS-web and is hereby incorporated by reference in its entirety. The ASCII copy as filed herewith was originally created on 10 Mar. 2021. The ASCII copy as filed herewith is named NREL 18-76A_ST25.txt, is 70 kilobytes in size and is submitted with the instant application.

BACKGROUND

Poly (ethylene terephthalate) (PET) is one of the most abundant manmade synthetic polyesters. Crystalline PET is being widely used for production of single-use beverage bottles, clothing, packaging, and carpeting materials. PET resistance to biodegradation due to limited accessibility to ester linkage, and disposal of PET products into the environment pose a serious threat to biosphere, particularly to marine environment. PET can be chemically recycled; however, the extra costs in chemical recycling are not justified when converting PET back to PET. Thus, there remains a need for alternative strategies for recycling/recovering/reusing PET.

SUMMARY

In an aspect disclosed herein is a genetically modified organism comprising an exogenous gene addition, wherein the exogenous gene addition encodes functional enzymes comprising a PETase and a MHETase, and the genetically modified organism is capable of metabolizing poly (ethylene terephthalate) (PET) to produce PET deconstruction products. In an embodiment, the genetically modified organism has an exogenous gene is from Ideonella sakaiensis. In another embodiment, the genetically modified organism has an exogenous gene is codon optimized. In another embodiment, the genetically modified organism has an exogenous gene is incorporated into the genome of the genetically modified organism. In another embodiment, the genetically modified organism has an exogenous gene addition further comprises genes encoding a secretion signal peptide. In another embodiment, the genetically modified organism has a genetically modified organism is a species of Pseudomonas. In another embodiment, the genetically modified organism is the species is Pseudomonas putida. In another embodiment, the genetically modified organism has PET deconstruction products comprise at least one of bis(2-Hydroxyethyl) terephthalate, mono-(2-hydroxyethyl) terephthalate, terephthalate, ethylene glycol, ß-ketoadipate, or muconate. In another embodiment, the method comprising contacting poly (ethylene terephthalate) (PET) with the genetically modified organisms of claims 1 to produce PET deconstruction products. In another embodiment, the method of claim 9, wherein the contacting is performed in minimal salt medium. In another embodiment, a genetically modified organism comprising an exogenous gene addition, wherein the exogenous gene addition encodes functional enzymes comprising a PETase and a MHETase, and the genetically modified organism is capable of metabolizing poly (ethylene terephthalate) (PET) to produce PET deconstruction products; and wherein said genetically modified organism further comprises heterologous TPA transporters. In another embodiment, the genetically modified organism further comprising catabolic gene clusters I or II. In another embodiment, the genetically modified organism wherein the catabolic gene clusters I or II are from Comamonas sp. E6. In another embodiment, the genetically modified organism is capable of using TPA as a sole carbon source. In another embodiment, the genetically modified organism is capable of metabolizing TPA at about 0.05 g L⁻¹ h⁻¹. In another embodiment, the genetically modified organism is lacking a pcaIJ gene. In another embodiment, the genetically modified organism is capable of metabolizing TPA to ß-ketoadipate. In another embodiment, the genetically modified organism is a species of Pseudomonas. In another embodiment, the genetically modified organism the exogenous gene is from Ideonella sakaiensis. In another embodiment, the genetically modified organism has a PET deconstruction products that comprise at least one of bis(2-Hydroxyethyl) terephthalate, mono-(2-hydroxyethyl) terephthalate, terephthalate, ethylene glycol, ß-ketoadipate, or muconate.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1A, FIG. 1B, FIG. 1C, FIG. 1D, FIG. 1E depict: FIG. 1A illustrates bright field microscopic observation of the strain expressing PETase with GFP tag; FIG. 1B illustrates microscopic observation of GFP signal of the strain expressing PETase with GFP tag; FIG. 1C illustrates GFP signal of the supernatant of wild-type strain and the strain expressing GFP tagged PETase; FIG. 1D illustrates immunoprecipitation of GFP tagged PETase with GFP specific GFP-Trap® (ChromoTek GmbH, Planegg-Martinsried, Germany); and FIG. 1E illustrates a microscopic image of PET particle incubated with the strain expressing GFP tagged PETase.

FIG. 2A, FIG. 2B, FIG. 2C, FIG. 2D, FIG. 2E, FIG. 2F, FIG. 2G, FIG. 2H, and FIG. 2I depict degradation results of PET by LJ041 (FIG. 2A) integrated gene cassette (FIG. 2B) visual observation of biofilm of 1141 on PET film (arrow) (FIG. 2C) fragmenting PET by LJ041 (FIG. 2D) SEM observation of PET particles cultured with KT2440, after 5 days of incubation (FIG. 2E) SEM observation of PET cultured with LJ041, and arrow indicates the biofilm on PET (FIG. 2F) SEM image revealed that KT2440 does not form biofilm on PET (FIG. 2G) SEM observation of LJ041 biofilm forming cells on PET (FIG. 2H) SEM observation of fragmenting PET film (highlighted area with arrow) by LJ041 (FIG. 2I) LJ041 forms holes on PET film (FIG. 2J) HPLC chromatographs of PET-degraded products after 24 h and 72 h. Experiments were conducted in 5 mL M9 medium containing 20 mM glucose and about 60 mg of amorphous PET particle.

FIG. 3 depicts strain LJ041 that was tested for selective degradation of BHET to TPA. The LJ041 strain converted BHET to TPA at 3-fold higher rate relative to wild-type P. putida KT2440 (LJ041:12.8 mg/L/h vs KT2440: 4.7 mg/L/h).

FIG. 4 depicts Engineered TPA catabolic pathway in P. putida KT2440, transporter TpaK and catabolic genes (TphA1, TphA2, TphA3, and TphB) are originally from R. jostii RHA1 and Comamonas sp. strain E6, respectively.

FIG. 5A, FIG. 5B, and FIG. 5C depict engineered P. putida KT2440 strains that enable TPA utilization. FIG. 5A depicts curves of the strain (FIG. 5B) growth rate of the strains (FIG. 5C) TPA utilization of the strains. Growth of the strains was assessed in minimal medium containing either 10 mM TPA or 10 mM PCA as the sole substrate for growth, and TPA utilization was measured during growth in minimal medium with 10 mM TPA as the sole growth substrate. Concentrations of TPA were measured using high performance liquid chromatography (HPLC) by injecting culture supernatant onto a Rezex RFQ-Fast Acid H+(8%) HPLC column. Mobile phase consisted of 5 mM H₂SO₄, and samples were run at 0.6 ml/min at 60° C. TPA eluted at ˜21 minutes and was detected at a wavelength of 230 nm via a UV-Vis detector. Area under the elution peak was integrated and TPA concentration was calculated against a standard.

FIG. 6A depicts codon optimized sequences of PETase (SEQ ID NO: 1) and FIG. 6B depicts codon optimized sequences of MHETase (SEQ ID NO: 2) genes from Ideonella sakaiensis 201-F6 to P. putida KT2440.

FIG. 7 depicts a plasmid map of pLJ080.

FIG. 8 depicts the nucleotide sequence of plasmid pLJ080 (SEQ ID NO: 3).

FIG. 9A depicts the amino acid sequence of PETase (SEQ ID NO: 4) and FIG. 9B depicts the amino acid sequence of MHETase (SEQ ID NO: 5).

FIG. 10 depicts a plasmid map of pLJ081.

FIG. 11 depicts the plasmid sequence (SEQ ID NO: 6) of PETase with GFP tag (pLJ081).

FIG. 12 depicts (SEQ ID NO: 7) the nucleotide sequence of synthetic tphC_II gene.

FIG. 13 depicts (SEQ ID NO: 8) the nucleotide sequence of synthetic tphA2_II gene.

FIG. 14 depicts (SEQ ID NO: 9) the nucleotide sequence of synthetic tphA3_II gene.

FIG. 15 depicts (SEQ ID NO: 10) the nucleotide sequence of synthetic tphB_II gene.

FIG. 16 depicts (SEQ ID NO: 11) the nucleotide sequence of synthetic tphA1_II gene.

FIG. 17 depicts (SEQ ID NO: 12) the nucleotide sequence of synthetic tpiB gene.

FIG. 18 depicts (SEQ ID NO: 13) the nucleotide sequence of synthetic tpiA gene.

FIG. 19 depicts (SEQ ID NO: 14) the nucleotide sequence of the local chromosomal sequence in strain IP103. Homology arms sequences are shown in italic. Synthetic ribosome binding sites are shown in bold. Coding sequences for tph genes are underlined.

FIG. 20 depicts (SEQ ID NO: 15) the nucleotide sequence of the local chromosomal sequence in strain IP131. Homology arms sequences are shown in italic. Synthetic ribosome binding sites are shown in bold. Coding sequences for tph, tpi and kanamycin selection marker genes are underlined.

FIG. 2I depicts growth and TPA concentration in a medium containing an engineered Acinetobacter baylyi ADP1 strain, IP103, expressing the tphC_IIA2_IIA3_IIB_IIA_II synthetic genes was grown in Acinetobacter minimal media in the presence of 5 mM terephthalic acid and 20 mM pyruvate.

FIG. 22 depicts TPA consumption over time of an engineered Acinetobacter baylyi ADP1 strain, IP 131, expressing the synthetic terephthalate transporter genes, tpiAB, as well as the tphC_IIA2_IIA3_IIB_IIA_II genes, and the parent strain, IP103, expressing only the tphC_IIA2_IIA3_IIB_IIA_II genes, were grown in Acinetobacter minimal media supplemented with 5 mM terephthalic acid and 20 mM pyruvate. The strains were fed only at the beginning of the experiment.

FIGS. 23a, 23b, 23c, and 23d depict conceptual process and metabolic pathways to enable open-loop upcycling of poly(ethylene terephthalate) (PET) to β-ketoadipate (βKA) by an engineered P. putida strain. (FIG. 23a) Conceptual overview of PET plastic upcycling to performance-advantaged nylon: chemocatalytic glycolysis to deconstruct PET to BHET, bioconversion of BHET to βKA, and processing of βKA to performance-advantaged nylon. The bioconversion process (highlighted in pink) is enabled in this body of work. (FIG. 23b) Chemocatalytic glycolysis with a titanium butoxide catalyst and ethylene glycol as the solvent depolymerizes PET into BHET. (FIG. 23c) A metabolic pathway for the conversion of BHET to βKA is engineered in P. putida. Enzymes displayed in pink are overexpressed; subscript indicates heterologous expression (Is, Ideonella sakiensis; RHA1, Rhodococcus jostii RHA1; E6, Comamomas E6); A symbols indicate a gene deletion. (FIG. 23d) Acidification and organic solvent extraction efficiently separates βKA (98%, 99+% purity) from culture broth. Steiglich esteriviation to dimethyl βKA enables polymerization with hexamethylenediamine to produce a performance-advantaged nylon. Abbreviations: MHET, mono(2-hydroxyethyl)terephthalic acid; TPA, terephthalic acid; DCD, 1,2-dihydroxy-3,5-cyclohexadiene-1,4-dicarboxylate; PCA, protocatechuic acid; EG, ethylene glycol PETase, PET hydrolase; MHETase, MHET hydrolase; TpaK, probable TPA transporter, MFS superfamily protein; TphA, TPA 1,2-dioxygenase; TphB, DCD dehydrogenase; PcaHG, PCA 3,4-dioxygenase; PcaB, 3-carboxy-cis,cis-muconate cycloisomerase; PcaC, 4-carboxymuconolactone decarboxylase; PcaD, 3-oxoadipate enol-lactonase; PcaIJ, 3-oxoadipate CoA-transferase; GlcDEF, glycolate oxidase; Gcl, glyoxylate carboligase; GclR, GclR transcriptional regulator.

FIGS. 24a, 24b, and 24c depict Growth and utilization of ethylene glycol (EG) by engineered P. putida. (FIG. 24a) Schematic of beneficial engineering modifications for EG catabolism. (FIG. 24b) Growth of RC002, MFL185, and RC024 in M9 minimal medium plus 100 mM EG as the sole carbon source. Growth was measured in a Tecan Infinite® F500 at 30° C. (FIG. 24c) Growth and EG concentrations of RC024 shaken flask cultivations in M9 minimal medium supplemented with 100 mM EG as the sole carbon source. Error bars represent the standard deviation among biological triplicates.

FIGS. 25a, 25b, 25c, 25d, and 25e depict the engineered catabolism of terephthalate (TPA) in P. putida. (FIG. 25a) Schematic of beneficial engineering modifications for TPA catabolism. (FIG. 25b) Growth rates in x mM PCA and x mM TPA for the four strain which grew in TPA (TDM083, TDM084, TDM086, and TDM087) and growth rate in x mM TPA for 1-2 evolved isolates from each strain. Growth was measured; n=3-4, average ±standard deviation is plotted. (FIG. 25c) Growth of serially passaged cultures of TDM087, provided as an illustrative example for the gradual growth improvements observed in TDM083, TDM084, TDM086, and TDM087 lineages. See Fig. S4 for growth profiles and rates across the ALE for all evolved lineages. (FIG. 25d) Growth of wild-type P. putida KT2440, TDM461, Comamonas sp. E6, R. jostii RHA1, and IP250 in 10 mM TPA. Growth was measured in a BioscreenC; n=3, average ±standard deviation is plotted. (FIG. 25e) Growth and TPA utilization of strain TDM461 in 45 mM TPA. Cultivations were performed in shaken flasks; n=2, average ±absolute difference is plotted.

FIGS. 26a, 26b, 26c, and 26d depict Engineered catabolism of bis(2-hydroxyethyl)terephthalate (BHET) in P. putida. (FIG. 26a) Schematic of additional engineering modifications for BHET catabolism. PETase and MHETase expression cassette was engineered into RC026 (containing EG and TPA engineering) to generate RC038. (FIG. 26b) Growth RC026 and RC038 cultivated in a BioscreenC® in M9 minimal medium supplemented with 10 mM BHET as the sole carbon source. Growth and analyte concentrations of RC038 cultivated in shaken flasks with M9 minimal medium supplemented with (FIG. 26c) ˜10 mM BHET as the sole carbon source or (FIG. 26d) ˜10 mM BHET plus 20 mM glucose and fed to 20 mM glucose every 24 h. Error bars represent the standard deviation among biological triplicates.

FIGS. 27a, 27b, 27c, 27d depict conversion of BHET to bKA in bioreactors. (FIG. 27a) Schematic of the cumulative P. putida engineering modifications which enabled bKA production from BHET. (FIG. 27b) Solid BHET powder was fed via a headplate port (amounts and times indicated by instantaneous BHET feed “X”s) to a final concentration of 31.5 g/L. (FIG. 27c) Cell growth (measured as OD₆₀₀) and measured concentrations of BHET, metabolic intermediates (MHET and TPA), and beta-ketoadipate (BKA) in bioreactor cultiations of AW165 in M9 minimal medium. Glucose was provided as a DO-stat in 2 mM pulses. The grey arrow indicates where one of the three reactors went offline. Error bars represent the standard deviation among three replicates before the grey arrow and absolute difference after the grey arrow. (FIG. 27d) bKA titer, yield, and productivity every ˜24 h. Errors are reported as indicated for (FIG. 27b).

FIGS. 28a and 28b depict the conversion of PET to βKA via sequential chemical and biological processes, the preparation of PET for bioconversion, PET flakes were depolymerized via glycolysis; the reaction product was pasteurized, or suspended in water and filtered, prior to addition to microbial cultivations, and substrate characterization. Growth and metabolite concentrations of AW165 cultivations in M9 minimal medium supplemented with 40 mM glucose and (FIG. 28a) 2.54 g/L pasteurized crude product solids plus 50 μM ampicillin, (FIG. 28b) 47% (v/v) crude product solution. Glucose was fed to 20 mM every 24 h. Error bars represent the standard deviation among biological triplicates.

FIGS. 29a, 29b, 29c depict Growth of engineered P. putida strains in ethylene glycol. Growth in M9 minimal medium supplemented with 20, 50, or 100 mM EG of (FIG. 29a) RC002 (P. putida ΔgclR), (FIG. 29b) MFL185 (P. putida fpvA:P_tac:gcl:hyi:glxR:ttuD:pykF P_tac*:glcDEFG:PP_3749), or (FIG. 29c) RC024 (P. putida ΔgclR P_tac:glcDEFG:PP_3749). * , a 49 bp mutation was found in the P_tac promoter, as described in Franden et al. (2021). Growth was monitored in a BioscreenC® as wideband absorbance every 15 min. Error bars represent the standard deviation among biological triplicates.

FIG. 30 depicts EG concentration and OD600 over time in non-inoculated controls. Analyte concentrations and OD600 of shaken flasks with M9 minimal medium supplemented with 100 mM EG. Error bars represent the standard deviation among biological triplicates.

FIGS. 31a and 31b depict growth of TPA ALE evolved isolates in 10 mM TPA over up-to 40 generations of serial passaging. (FIG. 31a) Growth curves for starting strains and end-point isolates (indicated by “e1” or “e2”). (FIG. 31b) Calculated growth rates for the eight starting strains and evolved lineages.

FIG. 32 depicts Growth of selected strains in 10 mM PCA or 10 mM TPA. Strain genotypes are provided in Table S3. Growth was monitored in a BioscreenC® as wideband absorbance every 15 min. Error bars represent the standard deviation among biological triplicates. Average growth rate for PCA and TPA is provided in the inset of each plot.

FIG. 33 depicts Engineered P. putida growth in 20 mM glucose. P. putida wild-type (WT), RC026 (P. putida P_tac:glcDEFG:PP_3749 ΔgclR ΔhsdM-hsdR::P_tac:tphA2_IIA3_IIB_IIA1_II-E6 fpvA:P_tac:tpaK_RHA1), and RC038 (P. putida P_tac:glcDEFG:PP_3749 ΔgclR::PETase_Is:MHETase_Is ΔhsdM-hsdR::P_tac:tphA2_IIA3_IIB_IIA1_II-E6 fpvA:P_tac:tpaK_RHA1) growth in M9 minimal medium supplemented with 20 mM glucose. Growth was monitored in a BioscreenC® as wideband absorbance every 15 min. Error bars represent the standard deviation across biological triplicates.

FIGS. 34a, 34b depict BHET and derived metabolite concentrations over time in non-inoculated controls. Analyte concentrations of shaken flasks with M9 minimal medium supplemented with (FIG. 34a) ˜10 mM BHET or (FIG. 34b) ˜10 mM BHET plus 20 mM glucose and feeding to 20 mM glucose every 24 h. Error bars represent the standard deviation among biological triplicates.

FIG. 35 depicts dissolved oxygen profiles from bioreactor. Agitation (rpm) was adjusted manually. Feed solution (100 g/L ammonium sulfate, 500 g/L glucose, 2% (v/v) antifoam) were pulsed to provide 2 mM glucose when the DO reached the 70% setpoint. BHET was added manually at the amounts and times indicated by black arrows.

FIGS. 36a, 36b depict BHET, derived metabolites, and beta-ketoadipate concentrations over time from crude reaction product from glycolysis on PET. OD₆₀₀ and metabolite concentrations of non-inoculated cultivations in M9 minimal medium supplemented with 40 mM glucose and (FIG. 36a) 2.54 g/L pasteurized crude product solids plus 100 mM ampicillin, (FIG. 36b) 47% (v/v) crude product solution. Glucose was fed to 20 mM every 24 h. Error bars represent the standard deviation among biological triplicates.

FIG. 37 depicts βKA yield from PET glycolysis crude solids or solution. Error bars represent the standard deviation among biological triplicates.

FIG. 38 depicts plasmid maps used in an embodiment disclosed herein.

FIG. 39 depicts plasmid maps used in an embodiment disclosed herein.

DETAILED DESCRIPTION

The present disclosure may address one or more of the problems and deficiencies of the prior art discussed above. However, it is contemplated that some embodiments as disclosed herein may prove useful in addressing other problems and deficiencies in a number of technical areas. Therefore, the embodiments described herein should not necessarily be construed as limited to addressing any of the particular problems or deficiencies discussed herein.

In an embodiment, disclosed herein is an engineered P. putida KT2440 co-expressing PETase and MHETase enzymes that selectively degrades PET into monomers, ethylene glycol and terephthalate (TPA). In another embodiment, disclosed herein are methods for making and using a highly efficient EG metabolizing P. putida KT2440 strain. Given that native P. putida does not have a TPA metabolic pathway, nor the proteins to transport TPA into the cell, the next metabolic engineering challenge for developing synthetic P. putida strain to plastic upcycling was enabling TPA catabolism in P. putida KT2440. TPA transporters and catabolic pathway have been characterized in several microorganisms including Comamonas sp. strain E6 and Rhodococcus jostii RHA1.

In an embodiment, disclosed herein are engineered P. putida KT2440 strains that use TPA through heterologous expression of a TPA transporter from Rhodococcus jostii RHA1 and catabolic genes from Comamonas sp. E6 (FIG. 4). In an embodiment, the pcaIJ gene was knocked out in the engineered strains, enabling the biological conversion of TPA to ß-ketoadipate. Ultimately, the engineered strains disclosed herein enable the upcycling of PET-derived TPA into atom-efficient ß-ketoadipic acid, a high-value chemical that can be used to produce a biodegradable plastic material with superior properties.

As disclosed herein, in an embodiment, TPA catabolism is enabled in P. putida KT2440 by heterologous expression of TPA transporters (tpaK) and catabolic genes cluster I or II from R. jostii RHAI and Comamonas sp. E6, respectively. The engineered, non-naturally occurring strains can use TPA as a sole carbon source and use TPA at about 0.05 g L⁻¹ h⁻¹. In an embodiment, the pcaIJ gene was knocked out in an engineered TPA utilizing strain. The strain could convert TPA to ß-ketoadipate. In another embodiment, TPA utilization strain can be engineered for consolidated bioprocessing of PET by enabling selective degradation of PET and ethylene glycol utilization. In an embodiment, strains could be evolved to enhance TPA catabolic rates.

The present disclosure also relates to a biological strategy for degrading PET, which can subsequently enable atom-efficient biological transformations to novel intermediates (e.g., ß-ketoadipate and/or muconate), which may be converted to high strength composites. PETase hydrolyses PET to produce bis(2-hydroxyethyl) terephthalate (BHET), mono-(2-hydroxyethyl) terephthalate (MHET), terephthalate (TPA), and ethylene glycol (EG), and MHETase catalyzes MHET to TPA and EG. Hence, as shown herein, co-expression of PETase and MHETase in an engineered strain can enable PET degradation to TPA and EG. Thus, in some embodiments of the present disclosure, a biological method is provided for the selective degradation of PET into PET monomers via co-expression and secretion of PETase and MHETase in Pseudomonas putida, which can grow well in simple minimal salt medium.

Therefore, the present disclosure relates to biological methods for the selective degradation of PET into PET monomers via co-expression PETase and MHETase in Pseudomonas putida, which can grow well in simple minimal salt medium. Among other things, I. sakaiensis PETase, ISF6_4831 and MHETase, ISF6_0224 genes were codon optimized for expression in KT2440 including their secretion signal peptides, which are compatible to the P. putida chaperone SecB-dependent secretion system. In addition, the genes were integrated into the P. putida genome with the tac promoter to enable constitutive expression. In certain embodiment, the term “tac”, “Ptac” and “P-Tac” may be used interchangeable to mean a tac promoter. The developed LJ041 strain formed a biofilm on PET. LJ041 enables highly-selectively degradation of PET into monomer TPA via BHET and MHET and confirmed secretion of PETase and MHETase enzymes via the chaperone-dependent native P. putida secreting system. These innovations could lead to a P. putida strain for selective biological degradation and conversion of PET into bio-derived chemical building blocks.

I. sakaiensis PETase, ISF6_4831 and MHETase, ISF6_0224 genes were codon optimized to KT2440 including their secretion signal peptides, which are compatible to the P. putida chaperone Sec-dependent secretion system. To confirm secretion of codon optimized PETase in P. putida via the I. sakaienesis secretion signal peptide, green fluorescent protein (GFP) was genetically linked to the C-terminus of PETase and expressed in P. putida. Efficient secretion of GFP-tagged PETase was confirmed via microscopy and immunoprecipitation, see FIG. 1: Panel A illustrates bright field microscopic observation of the strain expressing PETase with GFP tag; Panel B illustrates microscopic observation of GFP signal of the strain expressing PETase with GFP tag; Panel C illustrates GFP signal of the supernatant of wild-type strain and the strain expressing GFP tagged PETase; Panel D illustrates immunoprecipitation of GFP tagged PETase with GFP specific GFP-Trap® (ChromoTek GmbH, Planegg-Martinsried, Germany); and Panel E illustrates a microscopic image of PET particle incubated with the strain expressing GFP tagged PETase.

Next, referring to FIG. 2, the codon optimized PETase and MHETase genes were successfully integrated into the P. putida genome with the tac promoter to enable constitutive expression, and obtained the LJ041 strain (see Panel A). LJ041 formed a biofilm (see FIG. 2, Panels B, E, and G) on amorphous PET coupon and visually observed the fragmenting PET (see FIG. 2, Panels C and H). HPLC analysis revealed that LJ041 enabled highly-selectively degradation of PET into monomer TPA via BHET and MHET (see FIG. 2, Panel J). These results indicate that the codon-optimized signal sequences (which are codon optimized to KT2440), “ATGAACTTCCCTCGCGCGTCGCGCCTGATGCAGGCGGCGGTCCTCGGTGGTCTGAT GGCAGTCAGCGCCGCGGCCACC”, which encode “MNFPRASRLMQAAVLGGLMAVSAAATA”, and “ATGCAGACCACCGTCACCACTATGCTGCTGGCATCGGTCGCCCTGGCCGCC”, which is enclosed signal peptide “MQTTVTTMLLASVALAA”, for MHETase, respectively, are sufficient for enzyme secretion. These secretion signal peptides may be used for trafficking other proteins in P. putida via the Sec-dependent native P. putida secreting system. Of note, Ideonella sakaiensis 201-F6 grows only in rich-medium but not in the minimal salt medium (data not shown). Thus, the LJ014 has an advantage over the Ideonella sakaiensis 201-F6 as an industrial biocatalyst to degrade PET and to subsequently upgrade the degradation products into high-value chemicals. In addition, we introduced PETase and MHETase encoding genes into the genome of P. putida EM42 strain via deploying pLJ080 plasmid, the genome reduced version of P. putida KT2440, and developed LJ042 strain.

FIG. 2 illustrates degradation results of PET by LJ041 (Panel A) integrated gene cassette (Panel B) visual observation of biofilm of 1141 on PET film (arrow) (Panel C) fragmenting PET by LJ041 (Panel D) SEM observation of PET particles cultured with KT2440, after 5 days of incubation (Panel E) SEM observation of PET cultured with LJ041, and arrow indicates the biofilm on PET (Panel F) SEM image revealed that KT2440 does not form biofilm on PET (Panel G) SEM observation of LJ041 biofilm forming cells on PET (Panel H) SEM observation of fragmenting PET film (highlighted area with arrow) by LJ041 (Panel I) LJ041 forms holes on PET film (Panel J) HPLC chromatographs of PET-degraded products after 24 h and 72 h. Experiments were conducted in 5 mL M9 medium containing 20 mM glucose and about 60 mg of amorphous PET particle.

Next, the LJ041 strain was tested for selective degradation of BHET to TPA (see FIG. 3). The LJ041 strain converted BHET to TPA at 3-fold higher rate relative to wild-type P. putida KT2440 (LJ041:12.8 mg/L/h vs KT2440: 4.7 mg/L/h). Taken together, this innovation could lead to a P. putida strain for selective biological degradation and conversion of PET into bio-derived chemical building blocks.

Materials and Methods:

Plasmid construction: Q5 Hot Start High-Fidelity 2× Master Mix (New England Biolabs) and primers synthesized by Integrated DNA Technologies (IDT) were used in all PCR amplification. Plasmids were constructed using Gibson Assembly® Master Mix (New England Biolabs) according to the manufacturer's instructions. Primers used for PCR amplification and Gibson assembly are listed in Table 1. The vector, pBLT-2 (Addgene plasmid #22806) was used for plasmid-based overexpression of PETase with a green fluorescence protein (GFP) tag. Plasmids for gene integration were constructed in pK18sB, which is unable to replicate in P. putida KT2440, and contains the kanamycin-resistant marker to select for integration of the plasmid into the genome by homologous recombination and sacB to counter select for a second recombination event to subsequently remove the plasmid backbone from the genome. Detail of plasmids construction is provided in Table 2.

TABLE 1
List of Primers
Primer ID 5′-3′
oLJ227    GACATGATTACGAATTCGAGCTCGGTACCCGTGCGATTA
          CTGTGGGAG
oLJ232    CCGGAGGCTTTTGACTCGGAGGCGCGGCGCAGGC
oLJ228    CGGATAACAATTTCACACTGAGTATTGCCTGAACCG
oLJ229    TTCAGGCAATACTCAGTGTGAAATTGTTATCCGCTCACA
          ATTCCACACATTATACGAGCCGATGATTAATTGTCAACA
          GCTCTTCATCAAGTCAAAACACTATATAGGAACG
oLJ230    ATGTAATCCTTGTTATAGGCTGCAGTTCGCAGTGCG
oLJ231    ACTGCGAACTGCAGCCTATAACAAGGATTACATATAAGG
          GTATATCAAATGCAGACCACCGTCACC
oLJ233    TGCGCCGCGCCTCCGAGTCAAAAGCCTCCGGTCGGAGGC
          TTTTGACTTCAAAACCACCCTGCTGTCGATG
oLJ234    CGGCCAGTGCCAAGCTTGCATGCCTGCAGGAAATCTAAC
          TGCCTTCGCCC
oLJ406    TATGTTGTGTGGAATTGTGAGCGGATAACAATTTCACAC
          TTTCATCAAGTCAAAACACTATATAGGAACGAAAC
oLJ407    TCCGCACTGCGAACTGCAGCGGTGGTTCTGAGGAATCTT
          ACATGAGC
oLJ408    GTAAGATTCCTCAGAACCACCGCTGCAGTTCGCAGTGCG
oLJ409    AGTCCAGTTACGCTGGAGTCTGAGGCTCGTCCTGAATGA
          TCTACTTGTAGAGTTCGTC

TABLE 2
Plasmid construction details
Plasmid	Purpose	Construction detail
pLJ080	Genome integration of	The PETase genes cassette was amplified with
	overexpressing cassette of PETase	primers oLJ229 (Fwd) and oLJ230 (Rev), and
	and MHETase	MHETase oLJ231 (Fwd) and oLJ232 (Rev) using
		synthesizes gBlock as a temple. The 5′ homology
		region was amplified from P. putida KT2440
		genomic DNA with primers oLJ227(Fwd), and
		oLJ228 (Rev), and 3′ homology region was
		amplified with oLJ233 (Fwd) and oLJ234 (Rev).
		These products were assembled into pK18sB
		digested with SmaI and SalI.
pLJ081	Overexpressing PETase-GFP	A DNA fragment containing the PETase genewas
		amplified from pLJ080 with primers oLJ406
		(Fwd) and oLJ407 (Rev), and GFP gene fragment
		was obtained with primers oLJ408 (Fwd) and
		oLJ409 (Rev), amplified from GFP containing
		plasmid. This product was assembled into pBLT-2
		digested with XbaI and EcoRV.

The PETase and MHETase genes from Ideonella sakaiensis 201-F6 were codon optimized to P. putida KT2440 using online program Optimizer with a random approach (http://genomes.urv.es/OPTIMIZER/), gene fragments were synthesized at Integrated DNA Technologies, Inc, and obtained the double-stranded and linear gBlock, see FIG. 6. The plasmid used for of integration of codon optimize PETase and MHETase to P. putida KT2440 contain the approximately 0.7 kb homology region on either side of the intergenic region immediately after PP_1642 and PP_1643 of P. putida KT2440. Features include the tac promoter to drive gene expression and a tonB terminator situated behind the fragments cloned into the plasmid backbone, which are depicted in FIG. 7. Synthetic ribosomal binding site (sRBS) were designed using an online program from the Salis laboratory at Penn State University, in front of genes, the designed sRBS (TCATCAAGTCAAAACACTATATAGGAACGAAACC) of PETase was predicted to have a translation initiation rate (TIR) of 27306.09, and MHETase has a sRBS (TAACAAGGATTACATATAAGGGTATATCAA) with TIR of 32480.74. Plasmid sequence of pLJ80 is provided in Table S5 in the Appendix. The protein sequences of PETase and MHETase are provided in FIG. 8. Plasmid was transformed into competent NEB 5-alpha F′P E. coli (New England Biolabs) according to the manufacturer's instructions. Transformants were selected on LB plates containing 10 g/L tryptone, 5 g/L yeast extract, 5 g/L NaCl, and 15 g/L agar, supplemented with 50 μg/mL kanamycin grown at 37° C. The sequences of all plasmid inserts were confirmed using Sanger sequencing (GENEWIZ, Inc.).

Strain construction: P. putida KT2440 (ATCC 47054) was used as the basis of strain engineering and gene replacements were made using the antibiotic/sacB system of selection and counter-selection. In an embodiment, the properties and description of some strains disclosed herein is depicted in Table 3. To prepare electrocompetent cells of P. putida KT2440 strains, a modified sucrose-based protocol was used. The plasmid was introduced to competent cells via electroporated at 1.6 kV, 25 μF, 200 Ohms. The transformation was plated on an LB agar plate containing 50 μg/ml kanamycin antibiotics and incubated at 30° C. overnight. Initial colonies from the transformation plates were re-streaked on selective LB agar plates and grown at 30° C. overnight to obtain clonal transformants. For sucrose counter-selection, clonal transformants were streaked on YT plates containing 25% (YT+25%; w/v) sucrose (10 g/L yeast extract, 20 g/L tryptone, 250 g/L sucrose, 18 g/L agar), and incubated at 30° C. overnight. The single colony of P. putida KT2440 containing the PETase and MHETase genes were successfully isolated. The strain was analyzed for the correct gene replacement by performing a colony PCR at the site of integration. The LJ102 was constructed by transforming pLJ081 plasmid into P. putida KT2440, the plasmid map and sequence are provided in FIG. 10 and FIG. 11.

TABLE 3
Strains
Strain ID	Genotype	Description of strain
KT2440	P. putida KT2440	Wild-type P. putida KT2440 (ATCC 47054)
EM42	P. putida KT2440	Genome reduced strain derived from P. putida
	Δprophage 1-4 Δflagellum	KT2440 obtained from Victor de Lorenzo's
	ΔendA-1 ΔendA-2 ΔTn7	laboratory (Centro Nacional de Biotecnología
	ΔhsdRMS ΔTn4652	(CNB-CSIC), Madrid, Spain)
LJ102	KT2440 + pBTL-2-PETase_GFP	KT2440 containing the pBTL-2 plasmid with
		PETase and GFP
LJ041	KT2440 1642::Ptac::PETase-MHET	KT2440 with the PETase and MHETase cassette
		integrated within the intergenic region between
		PP_1642 and PP_1643
LJ042	EM42 PP 1642::Ptac::PETase-MHET	EM42 with the PETase and MHETase cassette
		integrated within the intergenic region between
		PP_1642 and PP_1643

PET and BHET degradation experiment: To assess the selective degradation of PET/BHET by the PETase and MHETase expressing strain, shake flask experiments were performed using 125 mL baffled flasks containing 25 mL modified M9 media (6.78 g/L Na₂HPO₄, 3.00 g/L K₂HPO₄, 0.50 g/L NaCl, 1.66 g/L NH₄Cl, 0.24 g/L MgSO₄, 0.01 g/L CaCl₂), and 0.002 g/L FeSO₄) supplemented with 20 mM of glucose and amorphous PET coupons (amorphous PET films with a crystallinity of 14.8±0.2%, synthesized at NREL) or BHET (Obtained from IBM Almaden Research Center, BHET was derived from waste PET bottles via chemical depolymerization process), and inoculated to OD₆₀₀ 0.1 with pre-culture. Pre-cultures of the strains were prepared by inoculating 25 mL M9 medium supplemented with 20 mM glucose in a 125 mL baffled flask to an OD₆₀₀ of 0.05-0.1 and incubating shaking at 225 rpm, 30° C. At mid log phase (OD₆₀₀ 0.5-1.0) cells were harvested by centrifugation at 13,000 rpm, and the cell pellets were washed twice and resuspended in M9 medium without a carbon source. Cultures were incubated shaking at 225 rpm, 30° C. 1 mL samples were collected periodically and subjected to HPLC analysis to detect the degraded products. After the fermentation, PET coupons were subjected to microscopic observation.

Scanning Electron Microscopy (SEM): Imaging by scanning electron microscopy (SEM) was performed using a FEI Quanta 400 FEG instrument under low vacuum (0.45 Torr) operating with the gaseous solid-state detector (GAD). Samples were prepared for imaging by fixation in 2.5% gluteraldehyde buffered in 1×PBS (EMS, Hatfield, PS), dehydration in an ethanol series, then freezing in liquid nitrogen followed by lyophilization. Dry samples were mounted on aluminum stubs using carbon tape, and sputter coated with 9 nm of Ir metal. Images were captured at a beam accelerating voltage of 24 keV.

High performance liquid chromatography (HPLC) analysis: Concentrations of TPA, MHET, and BHET were measured using HPLC by injecting 6 μL of 0.2-μm filter-sterilized culture supernatant onto an Agilent1100 series system (Agilent USA, Santa Clara, Calif.) equipped with a Phenomenex Rezex RFQ-Fast Fruit H+ column (Phenomenex, Torrance, Calif.) and cation H+ guard cartridge (Bio-Rad Laboratories, Hercules, Calif.) at 85° C. A mobile phase of 0.1N sulfuric acid was used at a flow rate of 1.0 mL/min. Diode array detectors were used for compound detection. Compounds were identified by relating the retention times and spectral profiles with standard HPLC grade pure compounds (Sigma Aldrich, St. Louis, Mo., USA) and the concentration of each compound was calculated based on a calibration curves generated using pure compounds.

To enable TPA catabolism in P. putida KT2440, genes for TPA transport and for conversion of TPA into protocatechuic acid (PCA), an intermediate metabolite of ß-ketoadipate pathway were introduced into the chromosome of P. putida strain KT2440. Three different operons containing genes required for TPA catabolism [two operons from Comamonas sp. E6 (operon I: tphA2I, tphA3I, tphBI, and tphA1I) and (operon II: tphA2II, tphA3II, tphBII, and tphA1II), and one from R. jostii RHA1 (tpaA1, tpaA2, tpaC, and tpaB)], and two different operons containing transport genes [one from Comamonas sp. E6 (tphC, tpiA, and tpiB) and one from R. jostii RHA1(tpaK) were tested in various combinations (Table 4). Additionally, each operon was placed under control of 3 different promoters of varying strengths (from strongest to weakest: P-Tac, P-549, P-Lac, P-3079). Those gene clusters were successfully integrated into a modified version of P. putida KT2440 that has 3 poly-attB genetic islands for DNA insertion via highly efficient phage integrase system.

TABLE 4
Generated strains of P. putida containing genes for terephthalic acid transport
and catabolism under control of promoters with varying strengths.
	Catabolic Genes	Transport Gene(s)
	Source			Source			TPA
TDM#	Organism	Operon	Promoter	Organism	Operon	Promoter	growth
56	Comamonas	tphA2IA3IBIA1I	P-Tac	Comamonas	tphC-	P-549	No
57	sp. E6		P-Tac	sp. E6	tpiBA		No
58			P-Lac				No
59	Comamonas	tphA2IIA3IIBIIA1II	P-Tac	Comamonas	tphC-	P-549	No
60	sp. E6		P-Tac	sp. E6	tpiBA		No
61			P-Lac				No
62	Rhodococcus	tpaA1A2CB	P-Tac	Comamonas	tphC-	P-549	No
63	jostii RHA1		P-Tac	sp. E6	tpiBA		No
64			P-Lac				No
65	Comamonas	tphA2IA3IBIA1I	P-Tac	Comamonas	tphC-	P-Lac	No
66	sp. E6		P-Tac	sp. E6	tpiBA		No
67			P-Lac				No
68	Comamonas	tphA2IIA3IIBIIA1II	P-Tac	Comamonas	tphC-	P-Lac	No
69	sp. E6		P-Tac	sp. E6	tpiBA		No
70			P-Lac				No
71	Rhodococcus	tpaA1A2CB	P-Tac	Comamonas	tphC-	P-Lac	No
72	jostii RHA1		P-Tac	sp. E6	tpiBA		No
73			P-Lac				No
74	Comamonas	tphA2IA3IBIA1I	P-Tac	Comamonas	tphC-	P-3079	No
75	sp. E6		P-Tac	sp. E6	tpiBA		No
76			P-Lac				No
77	Comamonas	tphA2IIA3IIBIIA1II	P-Tac	Comamonas	tphC-	P-3079	No
78	sp. E6		P-Tac	sp. E6	tpiBA		No
79			P-Lac				No
80	Rhodococcus	tpaA1A2CB	P-Tac	Comamonas	tphC-	P-3079	No
81	jostii RHA1		P-Tac	sp. E6	tpiBA		No
82			P-Lac				No
83	Comamonas	tphA2IA3IBIA1I	P-Tac	Rhodococcus	tpaK	P-549	Yes
84	sp. E6		P-Tac	jostii RHA1			Yes
85			P-Lac				No
86	Comamonas	tphA2IIA3IIBIIA1II	P-Tac	Rhodococcus	tpaK	P-549	Yes
87	sp. E6		P-Tac	jostii RHA1			Yes
88			P-Lac				No
89	Rhodococcus	tpaA1A2CB	P-Tac	Rhodococcus	tpaK	P-549	No
90	jostii RHA1		P-Tac	jostii RHA1			No

In an embodiment, thirty-five strains were generated, of which four had substantial growth with TPA as the sole carbon source. Each of the four strains that were able to metabolize TPA contained one of the two Comamonas sp. E6 catabolic operons (I or II) in combination with the R. jostii transporter. Robust expression was a requirement for TPA utilization, as growth was only detected when catabolic and transport genes were expressed from the strongest tested promoters (P-Tac or P-549). Of note, the growth data revealed that neither Comamonas sp. E6 TPA transporter nor R. jostii RHAI catabolic genes enable TPA catabolism in P. putida KT2440. Growth in minimal media containing either 10 mM TPA or 10 mM PCA was compared for each of the TPA catabolizing strains. An extended lag phase and about a 3-fold slower growth rate for all strains indicated that TPA is not used as efficiently as PCA as a substrate (FIGS. 5A and 5B, Table 5). However, quantification of TPA from late exponential phase cultures grown in minimal media with 10 mM TPA indicated that about 90% of TPA was consumed (FIG. 5C). Ongoing experiments are aimed at optimizing import and processing of TPA. Additionally, the ultimate objective of this project is to use P. putida for the valorization of TPA into other high value products, such as ß-ketoadipate. To that end, the genes that facilitate ß-ketoadipate consumption, pcaIJ, have been deleted from the TPA utilizing strains to allow ß-ketoadipate accumulation, and the strains have been confirmed by PCR.

TABLE 5
Growth characteristics of TPA utilizing strains of
P. putida in minimal medium containing either 10
mM TPA or 10 mM PCA as the sole growth substrate.
		Lag Phase	Growth Rate	Doubling Time
Strain	Substrate	(h)	(h−1)	(h)
TDM083	TPA	16.4 ± 0.1	0.108 ± 0.002	6.41 ± 0.13
TDM084	TPA	16.4 ± 0.8	0.102 ± 0.003	6.81 ± 0.20
TDM086	TPA	17.4 ± 0.9	0.099 ± 0.003	7.01 ± 0.19
TDM087	TPA	17.6 ± 0.5	0.099 ± 0.001	6.98 ± 0.07
KT2440	TPA	No Growth	No Growth	No Growth
TDM083	PCA	2.8 ± 0.0	0.395 ± 0.024	1.76 ± 0.10
TDM084	PCA	2.8 ± 0.0	0.378 ± 0.026	1.84 ± 0.13
TDM086	PCA	2.9 ± 0.1	0.327 ± 0.066	2.17 ± 0.40
TDM087	PCA	2.8 ± 0.3	0.311 ± 0.029	2.24 ± 0.22
KT2440	PCA	2.6 ± 0.3	0.300 ± 0.010	2.31 ± 0.08

Different versions of a synthetic operon coding for a terephthalic acid degradation pathway were constructed for chromosomal integration and expression in Acinetobacter baylyi ADP1. This operon includes codon-optimized versions of the genes tphC_IIA2_IIA3_IIB_IIA_II and tpiBA from Comamonas sp. E6 under control of a constitutive promoter, with each gene being preceded by a synthetic ribosome binding site sequence. The description and accession numbers for the wild-type Comamonas sp. E6 tphC_IIA2_IIA3_IIB_IIA_II and tpiBA genes are listed in Table 6. For the homologous recombination and insertion of the operon in the chromosome of Acinetobacter baylyi ADP1, upstream and downstream homology arms of ˜2000 bp were amplified from genomic DNA and assembled by overlap extension PCR to flank the synthetic genes. Linear DNA fragments were transformed into naturally competent Acinetobacter baylyi ADP1 cells as described in the literature.

TABLE 6
	Protein accession
Gene	number	Description
tphCII	BAE47084.1	Periplasmic terephthalate binding receptor
tphA2II	BAE47085.1	Oxygenase large subunit of terephthalate
		1,2-dioxygenase
tphA3II	BAE47086.1	Oxygenase small subunit of terephthalate
		1,2-dioxygenase
tphBII	BAE47087.1	1,2-dihydroxy-3,5-cyclohexadiene-
		1,4-dicarboxylate dehydrogenase
tphA1II	BAE47088.1	Reductase component of terephthalate
		1,2-dioxygenase
tpiB	BAN66715.1	Small transmembrane protein of the aromatic
		acids transporter
tpiA	BAN66716.1	Large transmembrane protein of the aromatic
		acids transporter

In a first shake-flask experiment, an engineered Acinetobacter baylyi ADP1 strain, IP103, expressing the tphC_IIA2_IIA3_IIB_IIA_II synthetic genes was grown in Acinetobacter minimal media in the presence of 5 mM terephthalic acid and 20 mM pyruvate, the latter being fed every 24 hours to support cell growth. As seen in FIG. 1, more terephthalic acid was consumed by IP103 than by the wild-type strain. The slight decrease in TPA concentration for the wild-type strain is an effect of the dilution caused by feeding daily with 20 mM pyruvate to support cell growth.

Genes expressing the terephthalate transporter from Comamonas sp. E6, tpiBA, were then similarly codon optimized and incorporated into the genome of IP103 downstream of the tphC_IIA2_IIA3_IIB_IIA_II genes, such that expression of all of these genes was driven as an operon by the same promoter. In a shake-flask experiment, this new strain expressing the synthetic terephthalate transporter genes, tpiAB, as well as the tphC_IIA2_IIA3_IIB_IIA_II genes, IP131, and the parent strain expressing only the tphC_IIA2_IIA3_IIB_IIA_II genes, IP103, were grown in Acinetobacter minimal media supplemented with 5 mM terephthalic acid and 20 mM pyruvate, fed only at the beginning of the experiment. As seen in FIG. 2, IP131 was able to degrade terephthalic acid more quickly, than IP103, indicating that expression of the terephthalate transporter improved the ability of this strain to metabolize this substrate.

Poly(ethylene terephthalate) (PET) is among the most widely consumed synthetic plastics and thus also a major component of plastic waste in landfills. The development of chemical catalysis approaches for PET depolymerization to monomers offers new options for both closed-loop recycling and open-loop upcycling of PET, the latter of which can leverage biological transformations to higher-value products. To that end, here we apply catalytic glycolysis to deconstruct PET to bis(2-hydroxyethyl) terephthalate (BHET). For BHET conversion to terephthalate and ethylene glycol, we engineer Pseudomonas putida KT2440 with PETase and MHETase enzymes from Ideonella sakaiensis. We further engineer P. putida to convert terephthalate to a performance-advantaged bioproduct, b-ketoadipic acid, and for improved utilization of ethylene glycol, a byproduct of BHET catabolism. In a bioreactor, we produce 15.1±0.6 g/L of b-ketoadipic acid (b KA) from BHET at 76±3% molar yield. Lastly, we demonstrate conversion of catalytically depolymerized PET to bKA. Overall, this work highlights the potential of tandem catalytic deconstruction and biological conversion as a means to upcycle waste PET.

The accumulation of plastics in landfills and the natural environment is now widely recognized to be a global pollution crisis. As a primary component of a holistic solution to address this global challenge, chemical recycling technologies hold considerable promise to break down waste synthetic polymers into processable intermediates, including the original monomers. The resulting intermediates from these deconstruction processes can be either reformulated into chemically identical materials, known as closed-loop recycling, or converted into new materials, known as open-loop recycling. Open-loop recycling offers the potential to both incentive the economics of waste plastics reclamation via the production of higher-value materials (upcycling), as well as produce new materials that are more readily recyclable than the parent polymer. For open-loop polymer recycling strategies, a portfolio of synthetic chemistry and synthetic biology-based transformations can be leveraged and combined to produce new building blocks.

Due to its widespread use in single-use beverage bottles, clothing, carpet, and food packaging, poly(ethylene terephthalate) (PET) has long been a primary target substrate for chemical recycling. Today, only single-use beverage bottles and other rigid PET materials are able to be recycled at any appreciable global scale via mechanical recycling, which primarily converts the polymer to lower-value textiles or fibers, meaning ultimately the plastic waste will still end its functional life in the landfill or into the natural environment. Chemical recycling approaches for PET offer the potential to dramatically increase the volume of material that can be recycled to include textiles, films, packaging, etc. Deconstruction strategies for PET into monomers include glycolysis, chemical hydrolysis, enzymatic hydrolysis methanolysis, and thermal depolymerization, among many emerging, catalysis-enabled options. Glycolysis is a particularly promising approach to depolymerize PET to bis(2-hydroxyethyl) terephthalate (BHET) in the presence of various catalysts when ethylene glycol is used as the reactant (and typically the solvent as well) (FIG. 23). Upon purification, BHET can be readily converted back to PET, or converted to higher-value products.

The potential for metabolic engineering, synthetic biology, biochemistry, and industrial biotechnology to play a role in chemical recycling of plastics is well recognized. For biological conversion of BHET to value-added chemicals, there are a considerable number of existing components that can be combined to enable its biological conversion. For BHET hydrolysis into its constituent building blocks, the two-component PETase and MHETase enzyme system discovered by Yoshida and co-workers from Ideonella sakaiensis 201-F6 converts BHET into terephthalate (TPA) and ethylene glycol (EG).16 Microbial conversion metabolic pathways for both PET building blocks, TPA and EG, have been reported. For EG, we previously reported engineering of the aromatic catabolic bacterium, Pseudomonas putida KT2440 (hereafter P. putida), to convert up to 2 M EG substrates in shake flasks cultivations by constitutive overexpression of native genetic machinery. Additional work using adaptive laboratory evolution (ALE) in the same strain also resulted in similar performance, and revealed the importance of a key regulator in EG catabolism in P. putida. The catabolic pathways for TPA, including both transporters and enzymes, have been described in diverse bacteria, including Comomonas sp. E6 (hereafter Comamonas), Rhodococcus jostii RHA1 (hereafter R. jostii), Pseudomonas sp. GO16, and I. sakaiensis 201-F6 (hereafter I. sakaiensis). Conveniently, TPA catabolism in these microbes all proceeds via protocatechuate (PCA), a central intermediate in aerobic aromatic catabolism including in P. putida.22 This central intermediate can be converted into aromatic catabolic intermediates such as muconic acid or β-ketoadipic acid, or converted to central carbon metabolism to produce any number of accessible products, such as polyhydroxyalkanoates.

In the current work, we present a metabolic engineering effort that culminates in a P. putida strain which expresses PETase and MHETase for BHET conversion to TPA, transforms TPA into a performance-advantaged bioproduct, β-ketoadipic acid, and rapidly utilizes the byproduct EG (FIG. 23). We conduct bioreactor cultivations to demonstrate 15.1±0.6 g/L βKA titers and demonstrate βKA biosynthesis from a crude PET chemocatalytic glycolysis product. Overall, this study contributes to the emerging literature in the use of metabolic engineering for the important problem of plastics upcycling.

Results

Deregulation and Overexpression of Native P. puitda Genes Improved EG Catabolism

Two units of EG are released for every BHET molecules (FIG. 23) and glycolyzed PET streams will likely contain trace EG despite solvent recycling. Robust tolerance to, and utilization of, EG is therefore required for a biocatalyst converting PET-derived BHET to βKA. P. putida natively catabolizes EG albeit slowly and in a heavily regulated process, likely due to the acute toxicity of pathway intermediates. Constituitive overexpression of the gclDEFG:PP_3794 and gcl:hyi:glxR:ttuD:pykF catabolic operons17 (strain MFL185) or deletion of the glcR repressor18 which de-represses expression of gcl:hyi:glxR:ttuD:pykF (strain RC002) (FIG. 23) have been shown to improve EG utilization but both engineering modifications had not yet been combined into a single strain.

We combined the overexpression of gclDEFG:PP_3794 and a gclR deletion into one strain, named RC024 (strain genotypes are provided in Table 1). RC024 was compared to RC002 and MFL185 in M9 minimal medium with 100 mM EG as the sole carbon source. As compared to MFL185, RC024 displayed an improved growth rate (0.26±0.0 vs. 0.17±0.01 h-1, respectively; p<0.05, paired one-tailed t-test) and decreased lag phase (11.7±0.5 vs. 16±1.1 h, respectively; p<0.05), whereas RC002 did not display any growth in 100 mM EG (FIG. 24a) but did at lower concentrations of 20 and 50 mM (FIG. 29). Evaluation in shaken flasks was conducted to confirm complete EG utilization. EG concentrations were stable in non-inoculated controls (FIG. 30). Complete utilization of 100 mM EG was observed within 24 h of RC024 cultivations (FIG. 24b). Together the growth data demonstrates combining deregulation (ΔgclR) and overexpression (P_tac:glcDEFG:PP_3749) of native P. puitda genes into a single strain improves EG utilizaiton.

TABLE 7
Bacterial strains utilized in this study. Strains for which data is provided in the main text are listed
here in alphabetical order; see Table 10 for a complete list and accompanying construction details.
Subscript indicates the host organism for heterologously expressed genes: E6, Comamonas sp. E6;
RHA1, Rhodococcus jostii RHA1; Is, Ideonella sakiensis.
Name	Genotype	Ref
P. putida	Wild-type Pseudomonas putida KT2440 (KT2440)	ATCC ® 47054
AW165	P. putida ΔhsdM-hsdR::Ptac:tphA2IIA3IIBIIA1II-E6 fpvA:Ptac:tpaKRHA1	This study
	Ptac:glcDEFG:PP_3749 ΔgclR::PETaseIs:MHETaseIs ΔpcaIJ
TDM083
TDM084
TDM086
TDM087
TDM461	P. putida ΔhsdM-hsdR::Ptac:tphA2IIA3IIBIIA1II-E6 fpvA:Ptac:tpaKRHA1	This study
MFL185
RC002	P. putida ΔgclR	This study
RC024	P. putida ΔgclR Ptac:glcDEFG:PP_3749	This study
RC025	P. putida ΔhsdM-hsdR::Ptac:tphA2IIA3IIBIIA1II-E6 fpvA:Ptac:tpaKRHA1	This study
	ΔgclR
RC026	P. putida ΔhsdM-hsdR::Ptac:tphA2IIA3IIBIIA1II-E6 fpvA:Ptac:tpaKRHA1	This study
	Ptac:glcDEFG:PP_3749 ΔgclR
RC038	P. putida ΔhsdM-hsdR::Ptac:tphA2IIA3IIBIIA1II-E6 fpvA:Ptac:tpaKRHA1	This study
	Ptac:glcDEFG:PP_3749 ΔgclR::PETaseIs:MHETaseIs
RC043	P. putida ΔhsdM-hsdR::Ptac:tphA2IIA3IIBIIA1II-E6fpvA:Ptac:tpaKRHA1	This study
	Ptac:glcDEFG:PP_3749 ΔgclR::PETaseS238F/W159HIs:MHETaseIs

RC002, MFL185, and RC024 in M9 minimal medium plus 100 mM EG as the sole carbon source. Growth was measured in a Tecan Infinite® F500 at 30° C. (c) Growth and EG concentrations of RC024 shaken flask cultivations in M9 minimal medium supplemented with 100 mM EG as the sole carbon source. Error bars represent the standard deviation among biological triplicates. Strain genotypes are provided in Table 7.

Heterologous Expression of tpaK and tphA2A3BA1 Enabled TPA Catabolism by P. putida.

TPA is the product of PETase- and MHETase-mediated BHET breakdown but is not natively catabolized natively by P. putida (FIG. 25d). TPA catabolism has been reported in Comomonas sp. E6, R. jostii, Pseudomonas sp. GO16, and I. sakaiensis, beginning by hydroxylation of the aromatic ring via a TPA dioxygenase (TphA) and followed by conversion to PCA via a diol dehydrogenase (TphB, FIG. 23). For heterologous expression in P. putida, we sourced two operons from Comamonas (tphA2IA3IBIA1I and tphA2IIA3IIBIIA1II) and a third from R. jostii, (tpaA1A2CB). Each operon was driven by one of three promoters: Ptac2, P549 (a lower expression Ptac derivative), or Plac. Three promoters and three catabolic operons combined to generate nine expression cassettes each built into a plasmid (Tables 8-10).

Aromatic carboxylates are predicted to minimally passively diffuse across a phospholipid bilayer akin to the bacterial inner membrane, so we hypothesized that active TPA transport is necessary for TPA catabolism in P. putida. In R. jostii, the TPA transporter is encoded by tpaK. In Comamonas, tphC and tpiBA are required for TPA uptake which were combined into a single operon for expression in P. putida. DNA constructs were built with both the P549 and Plac promoters, resulting in four plasmids (Tables 8-10).

A combinatorial library of 36 P. putida variants was built by moving one of the catabolic plasmids and one of the transport plasmids into the P. putida genome via insertion into a landing pad based on the previously-developed high efficiency site-specific recombination system.36 All isolates grew with PCA as the sole carbon source, as expected. Growth in TPA as the sole carbon source was observed only by four of the 36 strains—TDMM083, TDM084, TDM086, and TDM087—all of which harbor plasmids expressing the tpaK transporter combined with either tph catabolic operon from Comamonas (FIGS. 25a-b).

While these strains could grow in TPA, the growth rate was slow as compared to PCA (FIG. 25b). To enhance the grow rate on TPA, we performed ALE by serially passaging duplicate cultures of the four strains which grew on TPA for 26-40 generations in minimal medium with 10 mM TPA as the sole carbon source (FIG. 31, FIG. 25c). Single colonies were isolated from end-point populations (TDM083e2, TDM084e1, TDM086e1, TDM087e1, and TDM087e2) and displayed 3.2 to 5.2-fold increases in growth rate on TPA which was similar to growth rate on PCA (FIG. 31, FIG. 25c). Whole-genome Illumina sequencing revealed three SNPs in the tpaK promoter in two of the fastest growing strains that converted the P549 promoter into the stronger P_tac promoter suggesting that TPA uptake was rate limiting to growth.

Using this information, we inserted the best TPA catabolic and transport pathway designs into the P. putida chromosome via homologous recombination. Ptac:tphA2IIA3IIBIIA1II replaced the inactive Type I DNA-restriction system genes hsdRM (PP_4740-PP_4741), and Ptac:tpaK was inserted into the intergenic region following fpvA (PP_4217). The resulting strain, TDM461, displayed a growth rate of 0.39±0.20 h-1 in 10 mM PCA and 0.23±0.00 h¹ in 10 mM TPA (FIG. 32); this growth rate in TPA is slower than the evolved isolates but faster than Comamonas sp. E6 and R. jostii RHA1, the host organisms for the TPA catabolic and transport genes, respectively (FIG. 25d, FIG. 32). We also compared growth to IP250, a strain of A. baylyi our group previous engineered for TPA catabolism.37 IP250 had slightly slower growth rate (0.21 h⁻¹) as compared to TDM461 (FIG. 25d, FIG. 32). In confirmation of TPA catabolic activity, TDM461 utilized 45 mM TPA within 38 h of cultivation in shake flasks (FIG. 25e). Thus, while the growth improvement observed in ALE isolates was not fully recapitulated in TDM461, we considered the growth and utilization of TPA to be sufficient towards enabling BHET catabolism

Stacked Expression of PETase and MHETase Enabled BHET Catabolism by P. putida

Enzymatic conversion of BHET to TPA by I. sakaiensis occurs sequentially via two esterases, PETase and MHETase. To enable BHET conversion in P. putida, we first combined the TPA and EG genetic modifications described in the first two sections, generating strain RC026. For heterologous expression of PETase and MHETase, we maintained the I. sakiensis secretion signals, codon optimized each gene, designed synthetic RBSs, arranged a two-gene PETase:MHETase operon, drove expression via Ptac, and integrated this expression cassette into the chromosome at the gclR locus of RC026, generating strain RC038 (FIG. 26a, Table 9). RC038 had only a slightly decreased growth in 20 mM glucose as compared to RC026 (0.51±0.01 h-1 and 0.63±0.0 h-1, respectively) which was comparable to wild-type (0.53 h⁻¹, FIG. 33), indicating the accumulation of overexpressed enzymes did not incur an excessive metabolic burden. To assess microbial BHET mineralization, we solubilized BHET pellets in water via sonication (see Materials and Methods) and cultivated RC026 and RC038 in M9 minimal media supplemented with 10 mM BHET as the sole carbon source. RC026 did not grow, whereas RC038 grew with 12.2±1 h lag and 0.28 h-1 growth rate (FIG. 26b), which is 56% of the RC038 growth rate observed in 20 mM glucose (FIG. 33). This demonstrates PETase and MHETase expression is sufficient to enable catabolism of BHET in a RC026 background.

BHET, MHET, and TPA utilization dynamics were assessed in shaken flasks. Non-inoculated controls displayed 14±10% BHET degradation at 48 h of cultivation (FIG. 34), indicating a basal level of abiotic hydrolysis to MHET. Complete utilization of MHET and BHET was observed within 36 h by RC038 (FIG. 26c). Glucose supplementation increased the rate of BHET utilization (100% BHET utilization within 12 h) and reduced intermittent MHET accumulation (3.57 vs. 6.65 mM MHET at 6 h, FIG. 26d). These results suggest that MHETase activity is a bottleneck but can be largely alleviated by additional carbon/energy supplementation.

Bioconversion of BHET to β-Ketoadipate (βKA)

βKA can be polymerized into a nylon-6,6 analog with performance advantages, including a higher Tg and Tm, and a lower permeability.24 Notably, βKA is a metabolic intermediate of the βKA pathway, found in both bacterial and eukaryotic microrganisms—espeically soil-dwelling—for the degradataion of lignin-derived aromatics and environmental pollutants.41 In P. putida, ortho-cleavage of PCA by the PcaHG 3,4-dioxygenase (intradiol) generates a β-carboxymuconate moleucle which is converted to βKA by the PcaB, PcaC, and PcaD cycloisomerase, decarboxylase, and enol-lactonase activities, respectively (FIG. 23). To enable accumulation of βKA, we deleted pcaIJ, encoding 3-oxoadipate CoA-transferase, in RC038 to generate strain AW165 (FIG. 27a).

Bioreactors were employed to evaluate βKA production from BHET as pH control is necessary when producting the βKA acid. P. putida also produces 2-ketogluconic acid (2KGA) in excess when glucose accumulates. To mitigate 2KGA accumulation, a dissolved oxygen (DO)-stat strategy was used to limit glucose accumulation. Pulses of 2 mM glucose from a 500 g/L glucose, 100 g/L (NH4)2SO4, and 2% (v/v) antifoam feed solution were fed when the DO reached 70% (FIG. 35). In this way, glucose was supplemented to support cellular growth and maintenance while maintaining low glucose concentration.

BHET was fed separately from glucose via manual powder additions. We resorted to a solid feed because BHET solubility in water was so low it prohibited the preparation of a concentrated liquid stock. BHET power was ground, pasteurized, and added to the bioreactors via a port in the headplate (FIG. 27b). Solubilization of the power required several hours: white powder pelleted in samples such that accurrate quantification of BHET in solution was not achieved due to simultaneous solubilization and microbial conversion (FIG. 36). Thus, BHET addition was recorded based on the weight of the powder added in each feeding.

BHET powder was added to each of three bioreactors in five discrete manual feedings totalling 47 g (FIG. 27a). Cell density remained relatively constant after BHET feeding had begun (OD600 of 11.1 and 10.7 at 10 and 96.6 h, respectively) despite frequent feedings of glucose (FIG. 36), suggesting a high energetic demand for cell maintenance and/or bioconversion. Of the BHET intermediates, only TPA accumulated (FIG. 27c,). This result is aligned with our shaken flask experiments, and suggests TPA import or turnover is a bottleneck, especially at the latter timepoints.

At 96.6 h of cultivation, 31.5 g/L BHET had been converted to 15.1±0.6 g/L βKA at 76±3% molar yield and a productivity of 0.16±0.01 g βKA/L/h (FIG. 27d). The 76% molar yield, after accounting for resultial TPA, leaves a 10% error in the mol balance; we posit this error could be attributable to BHET powder which was not solubilized (e.g., physically stuck to the air-exposed baffles), trace impurities in the BHET powder, and instrumentation error. Yield and productivity fluctuated across the cultivation, reaching maximums of 0.85±0.02 mol/mol and 0.21 g/L/h at 72.2 and 48.2 h, respectively (FIG. 27c). This is the highest reported titer of an atom-efficient product from BHET—or any plastic-derived substrate—by an engineered microognamism, to our knowledge.

Biological Conversion of Chemically Depolymerized PET to βKA

Lastly, we pursued a proof-of-concept for tandem chemical deconstruction of PET followed by biological upcycling to βKA. Goodfellows Biaxially Oriented PET flakes were deconstructed via transesterification where ethylene glycol was used as the diol and titanium butoxide was used as the catalyst (FIG. 23b), as previously described.30 [FIG. 29b, FIG. 36-37].

We took a simple approach to prepare the crude reaction product for bioconversion (FIG. 28a). EG solvent was partially removed by filtration the wet solids were pasteurized, and added directly to microbial cultivations at a known weight. AW165 or non-inoculated controls were cultivated in M9 minimal medium supplemented with 40 mM glucose, 2.54 g/L pasteurized crude product, and 50 μM Ampicillin as a precaution against contamination via the crude product. BHET concentrations remained stable over time in non-inoculated controls; the presence of MHET at inoculation suggests pH- or temperature-induced BHET hydrolysis (FIG. 38, FIG. 28c). AW165 cellular growth, supported by glucose and EG, was not inhibited and 1.3 mM BHET plus 0.35 mM MHET present at inoculation was utilized within 36 (FIG. 28c,). At 24 h, 1.21±0.23 OKA was produced at 75±15% molar yield (FIG. 28b, FIG. 39). However, considering the substrate was provided as a solid which was partially insoluble, as with the bioreactor experiments, we could not be certain that the measured BHET at to captured the entirety of bioavailable substrate.

We also assessed bioconversion of a liquid suspension to enable accurate BHET quantification (no solids), avoid any heat-induced BHET degradation, and circumvent the need for antibiotic addition. The wet crude product was added to water, mixed at room temperature, and 0.2 μm filtered (FIG. 28a). AW165 reached a higher OD in cultivations with the crude product solution (48 h OD600=7.5±0.17) as opposed to the crude product directly (48 h OD600=3.9±0.67), suggesting toxic compounds from the glycolysis reaction were removed via filtration. Both BHET and MHET were present in the resulting solution which was free from solids such that quantification of analytes in the supernatant is representative (FIG. 28a), and concentrations were stable over time in non-inoculated controls (FIG. 38). After 24 h of cultivation, 3.11±0.06 mM of BHET and MHET were utilized, generating 1.39±0.01 mM OKA at a 45±1% molar yield (FIG. 28c, FIG. 39). Together, these results demonstrate conversion of PET-derived substrate to βKA is achievable with rudimentary preparation at the interface between chemical depolymerization and biological valorization.

DISCUSSION

Here, we present a chromosomally engineered P. putida strain capable of catabolizing TPA and BHET—the latter of which is a product of chemocatalytic PET depolymerization—as sole carbon sources (FIG. 25-26). We further engineer this strain to convert BHET to βKA, a monomer which can be polymerized into a nylon-6,6 analog with performance-advantaged properties. We report a titer of 15.1 g/L at a 75% molar yield from commercial BHET (FIG. 27), and demonstrate proof-of-concept microbial βKA production directly from chemocatalytically depolymerized PET (FIG. 28). In sum, this work establishes a framework for an integrated chemical and biological approach to open-loop upcycling of waste PET plastics to performance-advantaged products.

Catabolism of TPA is central to bio-upcycling of PET, and has been reported to occur in diverse bacteria including Nocardia, 43 Bacillus, 44 Rhodococcus, Comamonas, and Pseudomonas. Narancic et al. recently engineered P. putida KT2440 for TPA catabolism by heterologous, plasmid-based expression of the P. umsongensis GO16 TPA gene cluster (including tpaK, tphA1BA3A2, and iclR). Comparing the genetic elements from P. umsongensis GO16 to those engineered here (from Comomonas sp. E6 and R. jostii) in P. putida KT2440, or comparing the engineered P. putida KT2440 reported here to P. umsongensis GO16 when it becomes publicly available, would be a useful endeavor towards optimizing TPA catabolism in P. putida KT2440. Enzyme engineering and/or directed evolution of TphA (for which no structure has been reported) and TphB (for which the B. xenovorans LB400 structure has been solved) may further serve to improve TPA utilization rates, ultimately working to improve chemical productivities from depolymerized PET streams. Looking ahead, post-consumer PET waste streams will contain additives (e.g., dyes and plasticizers) that may not be catabolized by P. putida. Characterization of these streams to identify the chemicals present and engineering metabolic pathways for utilization thereof (perhaps preceded by bioprospecting for discovery the associated pathways) will be necessary to avoid toxic accumulation during the bioconversion process.

Metabolic engineering holds the potential to considerably improve the microbial chassis presented here. At the BHET loadings we used (<8 g/L instantaneous addition of solids), TPA accumulation was observed, suggesting that its catabolism is the rate-limiting step. As discussed above, efforts to improve TPA utilization should be pursued, for example, via adaptive laboratory evolution similar to our recent efforts with P. putida KT2440 and lignin-related aromatic compounds, to generate optimized TPA-catabolizing strains. Should the TPA bottleneck be overcome, improvement of BHET and MHET turnover may become necessary. Optimization of PETase/MHETase secretion and/or exploration of other PET hydrolases is of interest.

Bioprocess engineering will also be necessary to improve productivities and the feasibility of feeding solid plastic substrates. Adaptation of powder feeders to provide substrate in a timely (e.g., smaller feeds more routinely) and automated (e.g., supplied following a specified trigger) manner holds great potential. Examples of bioreactor configurations that accommodate solid feedings include fed-batch addition of pretreated corn stover via a mounted and automated powder feeder. Batch cultivations with solids—as is commonplace for wastewater treatment and the brewing of beer—is a promising alternative for substrates so long as chemical concentrations remain below the toxicity limit.

Biodegradation of plastics, defined as polymer depolymerization followed by subsequent monomer assimilation and mineralization, is considered as part of the solution to mitigate environmental (micro)plastic accumulation. Rigorous evaluation of the carbon fate from synthetic polymers is necessary to appropriately evaluate and classify the extent of microbial plastic degradation. A great example this comes from Yoshida et al., who reported I. sakaiensis performs PET depolymerization (via PETase and MHETase) followed by TPA assimilation and mineralization, constituting an example of microbial biodegradation of a fossil carbon-based plastic. Exogenous PETase and MHETase expression here enabled BHET catabolism (FIG. 26) but may also confer PET depolymerization capabilities, if effectual constituting a synthetic version of I. sakaiensis. Enzyme secretion, localization proximal to the substrate, and sustained extracellular activity is presumably paramount for microbial depolymerization of large polymeric substrates; similarities to cellulose degradation may exist and serve as inspiration for biotechnological development. Future work evaluating PET degradation of the herein reported P. putida against I. sakaiensis may reveal additional components important for improving microbial PET biodegradation.

Depolymerization of PET has been long studied via multiple approaches. Enzymatic hydrolysis, chemical hydrolysis, and thermolysis all produce the base monomers, TPA and EG. Conversely, chemical glycolysis (as conducted here) produces BHET when EG is used as the solvent, methanolysis produces dimethylterephthalate (DMT), and alcoholysis produces terephthalate diesters. Biological upcycling approaches, like that proposed here, are tunable to the deconstruction method and generated products. Indeed, the choice of deconstruction strategy will inform both the metabolic engineering approach and bioprocess needs, given the differences in catabolic enzyme needs. For example: both PETase and MHETase would be suitable for BHET (e.g., glycolysis product); MHETase, but not PETase, would be suitable for diester products of terephthalate (e.g., alcoholysis product); and only the TPA transport and catabolic genes would be necessary for TPA (e.g., hydrolysis and thermolysis products). Tandem deconstruction and upcycling approaches for PET will ultimately be determined by a combination of process feasibility and process modeling efforts to examine the economics and environmental impacts.58 We stress that the process option we demonstrated here is one of many that are conceptually feasible, and that judicious process analyses will be needed to compare among options, which we will examine in future efforts.

Materials and Methods

Bacterial Strains and Cultivation

Chemically competent NEB® 5-alpha F′Iq E. coli (NEB Cat. C29921) was cultivated at 37° C. shaking at 225 rpm in Miller's LB (Sigma Cat. L3522) supplemented with 50 μM kanamycin (Km). Pseudomonas putida KT2440 (ATCC® 47054, hereafter KT2440) and derived strains were cultivated in M9 minimal media (6.78 g/L Na2HPO4, 3 g/L KH2PO4, 0.5 g/L NaCl, 1 g/L NH₄Cl, 2 mM MgSO4, 100 μM CaCl2, and 18 μM FeSO4) at 30° C. shaking at 225 rpm. Glycerol stocks (20% (v/v)) were revived in LB, with the appropriate antibiotic for E. coli strains. M9 media was supplemented with carbon source(s), as indicated for each experiment. All chemicals were purchased from Sigma Aldrich unless specified otherwise. TPA stock solutions were made in water by gradually pH adjusting with NaOH; stocks were 0.2 μm filtered before use. Commercial BHET solution were made in water at a 2× concentration. Solubilization was achieved by sonicating the solution in a water bath for 1-1.5 h at 30° C. with periodic mixing; stocks were 0.2 μm filtered before use.

Plasmid Construction

Details on plasmid constructions can be found in Supplementary Tables 1-3. Briefly, Oligos were synthesized by Integrated DNA Technologies (IDT) unless otherwise specified. DNA amplification for plasmid constructions were performed via PCR with Q5® Hot Start High-Fidelity 2× Master Mix (NEB #M0494). Plasmid were assembled via Gibson Assembly or with NEB® NEBuilder HiFi DNA Assembly (NEB #E5520) and directly transformed into NEB® 5-alpha F′Iq E. coli for plasmid maintenance. Colony PCRs were performed with MyTaq™ Red Mix (Bioline #25043) and plasmid inserts were confirmed with Sanger Sequencing (GENEWIZ, Inc.). Plasmid maps for the TPA library pTM-series 202, 204, 205, 207, 208, 210, 211, and 212) are provided in Fig. S12.

Strain Construction

For construction of the TPA-catabolizing library, a modified strain of P. putida that contains several serine recombinase attB attachment sites at neutral loci served as the host (strain AG3454). AG3454 was simultaneously transformed with four plasmids, including a catabolic plasmid and a transport plasmid, which had different attP attachment sites corresponding to separate attB loci, and two plasmids that independently and transiently expressed the serine recombinases required for integration. Transformants were selected on LB plates (1.5% agar) containing both antibiotics for the catabolic plasmid (kanamycin, 50 μg/mL) and the transport plasmid (gentamicin, 30 μg/mL). Initial recombination into the chromosome was selected on LB plates containing 50 μg/mL kanamycin, and the second crossover event was counter-selected on YT+25% sucrose plates (10 g/L yeast extract, 20 g/L tryptone, 250 g/L sucrose, 18 g/L agar), and removal of plasmid backbone was confirmed by PCR and an inability to grow on LB plates with 50 μg/mL kanamycin, as previously described. All other chromosomal integrations and deletions in KT2440 were performed via the antibiotic/sacB method, as previously described. Correct integrations were confirmed by cPCR. Details on individual strain constructions can be found in Tables 8-10.

Adaptive Laboratory Evolution (ALE)

ALE was performed by serially passaging isolates in MME minimal medium (Table S5) with 10 mM TPA as the sole carbon source. Duplicate cultures of each TPA-utilizing isolate were started from individual colonies and continually passaged in fresh media upon reaching stationary phase. To evaluate the isolates, all isolates of the combinatorial library were tested for the ability to utilize TPA for growth. Overnight cultures were grown from individual colonies picked into LB with 50 μg/mL kanamycin and 30 μg/mL gentamicin. Cultures were washed once in MME minimal media (Table 9), and then inoculated (2% inoculum) into MME with either 10 mM PCA or 10 mM TPA.

Determination of TPA Consumption Rate

The rate of TPA consumption was measured by sampling of batch cultures grown in shake flasks at 30° C. A seed culture of P. putida TDM461 was grown overnight in MME with 50 mM TPA and was used to inoculate duplicate flasks of 25 mL Modified MME with 50 mM TPA at 10% inoculum. Trial experiments indicated growth was limited in standard MME with 50 mM TPA, and thus the following supplementations were made. Modified MME is based on the MME recipe from Supplemental Table 2, but with 2×NH₄C1 (1.0 g/L), 2× Trace Minerals (2 mL/L of 1000× solution), and 20 mM Tris(hydroxymethyl)aminomethane (Tris base). Periodically 1 mL samples were withdrawn, cells were pelleted by centrifugation, and the supernatant was stored at −20° C. The concentration of TPA in culture supernatants was measured on an Agilent 1260 Infinity II HPLC equipped with a Bio-Rad Fast Acid Analysis HPLC column. Prior to analysis, samples were thawed, acidified to a final concentration of 5 mM H₂SO₄ to match the mobile phase, and passed through a 0.45 μm filter. A peak for TPA eluted at around 21.5 min and was detected by the Agilent 1260 Infinity II Variable Wavelength Detector at 230 nm. TPA was completely consumed in less than 38 hours, and the maximum consumption rate was reached as the culture reached stationary phase (around 21 hours) and approximately 86% of TPA had been consumed.

Microtiter Plate Cultivations

Precultures were inoculated from glycerol stocks and grown overnight (12-16 h) in LB at 30° C. and 225 rpm, washed in 1×M9 salts, and inoculated into M9 minimal media supplemented with the carbon source(s) specified for each experiment. Tecan experiments were performed in an Infinite® F500 at 30° C. and OD600 was measured at 15 min. intervals. BioscreenC® (Growth Curves, USA) experiments were performed in honeycomb 100-well plates at 30° C., maximum shaking, and wideband absorbance (420-580 nm) was measured every 15 min.

Shaken Flask Cultivations with Model Substrate

Precultures were prepared and washed, inoculated at an OD600 of 0.1 in 30 mL of M9 minimal medium supplemented with the carbon source(s) as specified in 125 baffled metal-capped Erlenmeyer flasks, and cultivated at 30° C. with shaking at 225 rpm (0.75″). Growth was measured as absorbance at 600 nm (OD600). Samples were taken for metabolite analysis by removing 1 mL of culture, centrifuging at >18,000 g for 2 min, 0.2 μm syringe filtering the supernatant into glass vials, capping, and storing at −20° C. until analysis. Raw data for growth and metabolite abundance measurements for all shaken flask experiments are provided in.

Bioreactor Cultivations

Applikon In-Control 2.5 L bioreactors were sterilized and 1.2 L of M9 minimal medium (13.6 g/L NaHPO4, 6 g/L KH2PO4, 1 g/L NaCl, 2 g/L (NH₄)2SO4, 2 mM MgSO4-7H2O, 0.1 mM CaCl2-2H2O, 5 mg/L FeSO₄-7H2O, and 0.2 mL/L Antifoam 204) with 2.7 g/L glucose was added to each reactor. Triplicate AW165 seed cultures were prepared by reviving glycerol stocks in 50 mL LB and cultivating overnight at 30° C. and 225 rpm. The cells were washed in M9 minimal medium salts and inoculated into three bioreactors at an OD600 of 0.2 (˜5 mL washed seed culture per reactor).

A DO-stat glucose fed-batch with manual BHET feeding was employed. The feeding solution contained 100 g/L ammonium sulfate, 500 g/L glucose, 2% (v/v) antifoam 206. The feeding solution was aliquoted into three 300 mL bottles (one for each reactor) and pH adjusted with 350 uL of 4N NaOH per bottle. When the DO reached 70%, the feeding solution was pumped to provide 2 mM glucose. Agitation was manually adjusted to maintain frequent DO oscillations. Following 4 h of glucose batch phase, 1 mM 4HBA was added and the reactors were run for an additional 3.5 h prior to BHET addition. The poor solubility of BHET in water prevented preparation of concentrated stocks, so solid BHET feeding was employed. BHET flakes (Sigma Cat. 465151) were ground into small particles, heated at 70° C. for 1 h to pasteurize, weighed under aseptic conditions, and added to reactor via a port in the headplate at the times and amounts specified. To mitigate contamination via the open port during solid feeding, 50 μM ampicillin was added. The fermentations were harvested when DO oscillations became infrequent.

PET Deconstruction Via Glycolization

PET deconstruction via glycolysis was performed as previously described.30 Briefly, Goodfellows Biaxially Oriented PET flakes (Cat. #) were . . . . Following the reaction, the crude product was filtered for 2 h to remove excess EG. Characterization details

Shaken Flask Cultivations with Crude PET Reaction Product

For microbial cultivations in PET-derived BHET, solid and liquid feeds were prepared. For solid addition, the reaction product was filtered for 2 h to remove some EG, weighed, heated at 70° C. for 1 h to pasteurize, and added to media along with ampicillin (50 μM) to prevent microbial contamination. For liquid addition, the reaction product was weighed, added to deionized water, stirred at room temperature for 1 h, and 0.2 μm vacuum filtered. Preculture preparation and sampling was performed as in described in Shaken flask cultivation.

TABLE 8
Plasmids
Plasmid	Utility	Construction details
pK18mobsacB	Suicide vector for kanamycin/sucrose	ATCC ® 87097 ™, as described in
	selection and counterslection-mediated gene	Schäfer et al. (1994).1
	replacements in P. putida KT2440; Confers
	kanamycin resistance
pLJ062	pK18mobsacB-based vector for deletion	As described in Li et al. (2019).2
	of gclR from the KT2440 genome and derived strains	Alternatively: The 5′ homology region
		(1060 bp) was amplified from P. putida
		KT2440 genomic DNA with primers oLJ426
		(Fwd), and oLJ427 (Rev), and 3′ homology
		region (1060 bp) was amplified with oLJ428
		(Fwd) and oLJ429 (Rev). These products were
		assembled into pK18sB digested with
		EcoRI and HindIII.
pRC001	pK18mobsacB-based vector for insertion	The pMFL191 backbone (see
	of the Ptac promoter in front of the gcl operon in the	Franden et al. 20183, 4) was amplified with
	chromosome of KT2440 and derived strains	oCJ915 and oCJ916 (5,107 bp) where the
		primers contain the Ptac promoter sequence.
		The product was DpnI digested, purified, and
		transformed into NEB F'Iq E. coli. cPCR
		confirmation with oCJ546 and oCJ547
		(2,360 bp) was followed by Sanger
		sequencing (oCJ906, oCJ907, oCJ913,
		oCJ914, oCJ546, oCJ547).
pLJ039	Template for construction of pRC001	A gBlock containing codon
		optimized PETase and MHETase
		(gBlock_PETase_MHETase, Table S2) was
		synthesized). The DNA fragments were
		amplified from gBlock_PETase_MHETase
		with oLJ189 and oLJ190 and assembled into
		pBLT-2 digested with XbaI and EcoRV.
		(Construction detail are available at
		notebook PET upcycling #1, Book 6752,
		page 023
pRC001	Template for construction of pRC004	The PETase:MHETase gene
		cassette was amplified from pLJ039 with
		oCJ929 and oCJ930 (5,326 bp), DpnI
		digested, and transformed into NEB F'Iq
		E. coli. cPCR confirmation with oCJ054 and
		oLJ484 (378 bp) was followed by Sanger
		sequencing with oCJ531, oCJ920, oCJ921,
		oCJ922, and oCJ934.
pRC004	pK18mobsacB-based vector for insertion	The PETase:MHETase gene
	of the PETase and MHETase genes from I. sakiensis	cassette was amplified from pRC001 with
	into the chromosome of KT2440 with simultaneous	oCJ935 and oCJ936 (3,003 bp). The plasmid
	gclR deletion and derived strains	backbone with gclR homology regions was
		amplified from pLJ062 with oCJ937 and
		oCJ098 (5,048 bp). The reaction products
		were purified and assembled via HiFi
		Assembly and transformed into NEB F'Iq
		E. coli. cPCR confirmation with oCJ546
		and oCJ547 (5,232 bp) was followed by
		Sanger sequencing (oCJ546, oCJ547, oCJ920,
		oCJ921, oCJ922, oCJ928, oCJ947, oCJ948).
pCJ059	pK18mobsacB-based vector for deletion	As described in Johnson et al. (2019).5
	of pcaIJ from the chromosome of KT2440 and
	derived strains
pGW31	BxB1 serine recombinase expression;
	apramycin resistance (AAC(3)-IV).
pGW39	R4 serine recombinase expression;
	apramycin resistance (AAC(3)-IV).
pTM202	Site-specific integrating plasmid; BxB1
	attP; kanamycin resistance (nptII).
	Ptac-tphA2IA3IBIA1I
	(Comamonas sp. E6)
pTM204	Site-specific integrating plasmid; BxB1
	attP; kanamycin resistance (nptII).
	Plac-tphA2IA3IBIA1I
	(Comamonas sp. E6)
pTM205	Site-specific integrating plasmid; BxB1
	attP; kanamycin resistance (nptII).
	Ptac-tphA2IIA3IIBIIA1II
	(Comamonas sp. E6)
pTM207	Site-specific integrating plasmid; BxB1
	attP; kanamycin resistance (nptII).
	Plac-tphA2IIA3IIBIIA1II
	(Comamonas sp. E6)
pTM208	Site-specific integrating plasmid; BxB1
	attP; kanamycin resistance (nptII). Ptac-tpaA1A2CB
	(Rhodococcus jostii RHA1)
pTM210	Site-specific integrating plasmid; BxB1
	attP; kanamycin resistance (nptII). Plac-tpaA1A2CB
	(Rhodococcus jostii RHA1)
pTM211	Site-specific integrating plasmid; R4 attP;
	gentamicin resistance (AAC(3)-I). P549-tphCI-tpiBA
	(Comamonas sp. E6)
pTM212	Site-specific integrating plasmid; R4 attP;
	gentamicin resistance (AAC(3)-I). Plac-tphCI-tpiBA
	(Comamonas sp. E6)
pTM214	Site-specific integrating plasmid; R4 attP;
	gentamicin resistance (AAC(3)-I). P549-tpaK
	(Rhodococcus jostii RHA1)
pTM215	Site-specific integrating plasmid; R4 attP;
	gentamicin resistance (AAC(3)-I). Plac-tpaK
	(Rhodococcus jostii RHA1)
pTM219	pK18mobsacB based plasmid; nptII, sacB.
	Ptac-tpaK flanked by homology arms for insertion
	between PP_4717-PP_4718
pTM232	pK18mobsacB based plasmid; nptII, sacB.
	Ptac-tphA2IIA3IIBIIA1II flanked by homology arms
	for replacement of PP_4740-PP_4741

TABLE 9
Oligonucleotides
Oligo	Sequence (5′ → 3′)	Desc.
oCJ366	CGATTGCGCCATGAACAG	cPCR
oCJ367	AGGCTGCCGAGTATCATG	confirmation of genomic
		pcaIJ deletion
oCJ911	TTGAATTCGAGCTGTTGACAATTAATCATC
oCJ912	GACCTCGAGGATACGGTTG	cPCR
		confirmation of genomic
		Ptac integration prior to
		gIcDEFG:PP_3749
oLJ426	AAACAGCTATGACATGATTACGAATTCGAGCTCGG	PCR amplification
	TACCCCGTGGTGCTGGACTACAAGG	of the upstream homology
oLJ427	TCTTCGTGCCTCGAGAGCCCTCGTTTGCCTGCGT	arm for deletion of gcIR
	GATCG	from P. putida gDNA
oLJ428	TCGATCACGCAGGCAAACGAGGGCTCTCGAGGCA	PCR amplification
	CG	of the downstream
oLJ429	TGTAAAACGACGGCCAGTGCCAAGCTTGCATGCC	homology arm for deletion
	TGCAGGCGGCATCGACATCACCCC	of gcIR from P. putida
		gDNA
oLJ430	CCTTCTGCCCCACCTCCA	cPCR
oLJ431	CCCCCGCAGCACTCT	confirmation of genomic
		gcIR deletion
oCJ546	ATAGTCCTGTCGGGTTTC	Sequencing and
oCJ547	CCATCTTGTTCAATCATGCG	cPCR reactions of inserts
		into pK18mobsacB as
		specified in Table S1.
oCJ915	AATTAATCATCGGCTCGTATAATGTGTGGAATTGT	PCR amplification
	GAGCGGATAACAATTTCACACCGGAGGGAGTTTTGCGATG	of the pMFL191 (see
	AATATCCTGTACGACGAACGCGTCG	Franden et al. 20183, 4)
oCJ916	CCACACATTATACGAGCCGATGATTAATTGTCAAC	backbone. The underlined
	AGCTCGAATTCAAAAAACCGCACCTGGGTGCG	regions contains the Ptac
		promoter sequence.
oLJ189	GGAATTGTGAGCGGATAACAATTTCACACTTCATC	PCR amplification
	AAGTCAAAACACTATATAGGAACGAAACCATGAACTTCCC	of
oLJ190	CGCTGGAGTCTGAGGCTCGTCCTGAATGATCGGA	gBlock_PETase_MHETase
	GGCGCGGCGCAGGC
oCJ906	CTTCGCCAACAACAACAAAAACCG	Sanger
oCJ907	CCTGCGGGTTGACCTCGA	sequencing of pRC001
oCJ913	GTAGCACCCGCCTGCC
oCJ912	GACCTCGAGGATACGGTTG
oCJ929	GCTTGACAATTAATCATCGGCTCGTATAATGTGTG	PCR amplification
	GAATTGTGAGCGGATAAC	of pLJ039
oCJ930	TTATACGAGCCGATGATTAATTGTCAAGCCTGGGG
	TGCCTAATGCAAAATC
oCJ054	ATCGGCTCGTATAATGTGTGG	cPCR
oLJ484	GGCCCCACCACTTGATCGA	confirmation of pRC001
		and pRC002 construction
oCJ935	CCCCTCGATCACGCAGGCAAACGAAGTCAAAAGC	PCR amplification
	CTCCGGTC	of the PETase:MHETase
oCJ936	CTTCGTGCCTCGAGAGCCCAAAACTAAAGCGCCA	gene insert from pRC002
	CAAGGG
oCJ920	GCAAAGTGGACACCGCTC	Sanger
oCJ921	GTAGTTGAAGTGGCCGCATG	sequencing of the insert
oCJ922	CATCCTCGGTACTTGCGATG	DNA sequence for
oCJ947	GTTCCTCGTCCCAGGCATG	pRC004
oCJ948	GCCCCTACGCTGGATCTTGC
oCJ928	GAAGGCGAAGGCGACAC
gBlock_PETase_MHETase	GAGCTGttgacaattaatcatcggctcgtataatgTGTGGAATTG	The PETase and
	TGAGCGGATAACAATTTCACACTCATCAAGTCAAAACACTATATA	MHETase from Ideonella
	GGAACGAAACCatgaacttccctcgcgcgtcgcgcctgatgcagg	sakaiensis strain 201-F6
	cggcggtcctcggtggtctgatggcagtcagcgccgcggccaccg	were codon optimized for
	ctcagaccaacccatacgcccgcggcccaaaccctaccgcggcca	expression in P. putida
	gcctggaagcctctgccggcccattcaccgtgcgcagcttcaccg	KT2440 using the
	tcagtcgcccgtcgggctatggtgccggcaccgtctactacccaa	OPTIMIZER software
	ccaacgctggcggcaccgtcggcgccatcgcaatcgtgccgggct	(http://genomes.urv.es/
	ataccgcccgccagtcctcgatcaagtggtggggcccacgtctgg	OPTIMIZER/) random guided
	cctcccacggcttcgttgttatcaccatcgacaccaactcgaccc	method. PETase is shown
	tggaccagccgtcctcccgctcgagccagcagatggctgctctgc	in lowercase blue;
	gccaggtagcttcgctgaacggcaccagctctagcccaatctacg	MHETase is shown in
	gcaaagtggacaccgctcgcatgggcgtgatgggttggtccatgg	UPPERCASE PURPLE.
	gcggtggtggttccctgatctccgctgctaataatccttccctga	Synthetic RBSs (Green
	aggccgccgccccgcaggccccatgggactcctcgaccaacttct	underline) were
	cgagcgtgaccgtgccgaccctgatcttcgcttgcgaaaacgaca	designed using the Salis
	gcatcgctccggtgaactcctccgcgctgcctatctacgactcca	Lab RBS Calculator v2.1
	tgagccgcaacgccaagcaattcctggaaatcaacggcggttccc	(https://salis.psu.edu/software/)
	actcctgcgctaactcgggcaactcgaaccaagccctgatcggca	such that the RBSs
	agaagggcgtagcatggatgaagcgtttcatggataacgacaccc	had predicted translation
	gttactcgaccttcgcctgcgaaaacccgaactctactcgcgtca	initiation rates of 27306.09
	gcgacttccgcactgcgaactgcagcTAACAAGGATTACATATAA	and 32480.74 T.I.R for
	GGGTATATCAAATGCAGACCACCGTCACCACTATGCTGCTGGCAT	PETase and MHETase,
	CGGTCGCCCTGGCCGCCTGCGCAGGCGGCGGCAGCACCCC	respectively. The tac
	GCTGCCGCTGCCGCAGCAACAGCCGCCACAGCAGGAGCC	promoter (red underline)
	GCCGCCTCCTCCAGTCCCGCTGGCTTCCCGTGCTGCGTG	was also incorporated at
	TGAGGCCCTGAAGGACGGCAACGGGGACATGGTTTGGCC	the 5′ end to drive
	GAACGCCGCCACCGTAGTTGAAGTGGCCGCATGGCGCGA	expression of these genes.
	CGCTGCCCCGGCTACCGCGTCCGCCGCCGCTCTGCCGGA
	ACACTGCGAAGTTAGCGGCGCCATCGCCAAGCGCACTGG
	TATTGACGGTTATCCGTACGAAATCAAGTTCCGCCTGCGC
	ATGCCGGCGGAGTGGAATGGCCGTTTCTTCATGGAGGGT
	GGTTCCGGCACCAACGGCTCCCTGAGCGCGGCCACCGGC
	AGCATCGGTGGCGGCCAGATCGCCTCGGCCCTGTCCCGC
	AACTTCGCCACCATCGCGACCGACGGTGGCCACGACAAC
	GCTGTCAACGACAATCCAGACGCCCTGGGTACGGTAGCGT
	TCGGCCTGGACCCACAGGCTCGCCTGGACATGGGTTACA
	ATTCGTACGACCAGGTGACCCAAGCTGGCAAAGCCGCCGT
	TGCCCGTTTCTACGGCCGTGCCGCCGACAAGTCGTACTTC
	ATCGGCTGCTCGGAAGGTGGTCGGGAGGGCATGATGCTC
	AGCCAACGCTTCCCATCCCACTACGACGGTATCGTCGCCG
	GTGCCCCTGGCTACCAGCTGCCTAAAGCCGGTATCTCGG
	GCGCTTGGACCACTCAGTCGCTGGCCCCGGCGGCGGTGG
	GCCTGGACGCTCAGGGCGTCCCGCTGATCAACAAGAGCT
	TCTCCGATGCCGACCTGCACCTGCTGTCGCAGGCCATCCT
	CGGTACTTGCGATGCGCTGGACGGCCTGGCTGACGGCAT
	CGTTGACAACTACCGCGCGTGCCAGGCCGCTTTCGACCC
	GGCTACCGCGGCTAACCCTGCCAACGGTCAAGCTCTGCAA
	TGTGTGGGTGCCAAAACCGCCGATTGCCTGAGCCCGGTA
	CAGGTTACCGCCATCAAACGTGCAATGGCCGGCCCGGTC
	AACAGCGCCGGCACCCCGCTGTACAACCGTTGGGCCTGG
	GACGCTGGTATGAGCGGCCTGTCCGGTACCACCTACAATC
	AGGGCTGGCGTTCCTGGTGGCTGGGTAGCTTCAACTCCTC
	GGCGAACAACGCGCAGCGTGTTTCGGGTTTCTCCGCCCG
	CTCCTGGCTGGTCGACTTCGCCACCCCACCAGAGCCTATG
	CCGATGACCCAGGTGGCTGCACGCATGATGAAATTCGACT
	TCGACATCGACCCGCTGAAGATCTGGGCCACCAGCGGCC
	AGTTCACCCAGTCGAGCATGGACTGGCACGGGGCCACCT
	CCACCGACCTGGCCGCCTTCCGCGATCGTGGCGGCAAGA
	TGATCCTGTACCACGGTATGAGCGACGCAGCCTTCTCGGC
	CCTGGACACCGCTGACTACTACGAACGCCTGGGCGCCGC
	TATGCCGGGCGCCGCGGGCTTCGCTCGTCTGTTCCTCGT
	CCCAGGCATGAACCACTGTTCGGGCGGTCCAGGTACCGA
	CCGTTTCGACATGCTGACCCCTCTGGTGGCGTGGGTTGAG
	CGCGGCGAAGCCCCGGACCAGATCTCGGCGTGGAGCGG
	CACCCCAGGCTACTTCGGCGTCGCTGCCCGTACCCGCCC
	GCTGTGCCCGTACCCGCAAATCGCACGCTACAAGGGTTCC
	GGCGATATCAACACCGAAGCAAACTTCGCCTGCGCCGCG
	CCTCCG

TABLE 10
Strains. Subscript indicates the host organism for heterologously expressed genes.†
Strain Name	Genotype	Construction details	Ref
NEB ® 5-alpha	F′ proA+B+ lacIq Δ(lacZ)M15	N/A	NEB Cat.
F′Iq	zzf::Tn10 (TetR)/fhuA2Δ(argF-lacZ)U169		C2992
E. coli	phoA glnV44 Φ80Δ(lacZ)M15 gyrA96
	recA1 relA1 endA1 thi-1 hsdR17
P. putida	Wild-type Pseudomonas putida KT2440		ATCC ®
	(KT2440)		47054
AG3454	P. putida KT2440 with serine recombinase	See Elmore et al. (2017)6 for	Elmore et al.
	attB attachment sites. ΔPP_2876::A118	details.	(2017)6
	attB - MR11 attB - SPBc attB - ϕ370 attB;
	PP_4717-PP_4778::RV attB - TG1 attB -
	R4 attB - BL3 attB; ΔPP_4740-
	PP_4741::BxB1 attB - ϕBT1 attB-ϕK38
	attB - ϕC1 attB
TDM461	P. putida KT2440 ΔhsdM-		This study
	hsdR::Ptac:tphA2IIA3IIBIIA1II-E6
	fpvA:Ptac:tpaKRHA1
RC002	P. putida KT2440 ΔgclR	pLJ062 was transformed into	This study
		KT2440. Deletion of gclR was
		confirmed by cPCR with oLJ430
		and oLJ431 (2.5 kB).
RC024	P. putida KT2440 ΔgclR	pRC001 was transformed into	This study
	Ptac:glcDEFG:PP_3749	RC002. Integration of the Ptac
		promoter was confirmed by cPCR
		with oCJ911 and oCJ912 (436 bp).
RC025	P. putida KT2440 ΔhsdM-	pLJ062 was transformed into	This study
	hsdR::Ptac:tphA2IIA3IIBIIA1II-E6	TDM461. Deletion of gclR was
	fpvA:Ptac:tpaKRHA1 ΔgclR	confirmed by cPCR with oLJ430
		and oLJ431 (2.5 kB).
RC026	P. putida KT2440 ΔhsdM-	pRC001 was transformed into	This study
	hsdR::Ptac:tphA2IIA3IIBIIA1II-E6	RC025. Integration of the Ptac
	fpvA:Ptac:tpaKRHA1 Ptac:glcDEFG:PP_3749	promoter was confirmed by cPCR
	ΔgclR	with oCJ911 and oCJ912 (436 bp).
RC038	P. putida KT2440 ΔhsdM-	pRC004 was transformed into	This study
	hsdR::Ptac:tphA2IIA3IIBIIA1II-E6	RC026. Integration of the PETase
	fpvA:Ptac:tpaKRHA1 Ptac:glcDEFG:PP_3749	and MHETase genes was
	ΔgclR::PETaseIs:MHETaseIs	confirmed by cPCR with oLJ430
		and oLJ431 (5.5 kB).
AW165	P. putida KT2440 ΔhsdM-	pCJ059 was transformed into	This study
	hsdR::Ptac:tphA2IIA3IIBIIA1II-E6	RC038. Deletion of pcaIJ was
	fpvA:Ptac:tpaKRHA1 Ptac:glcDEFG:PP_3749	confirmed by cPCR with oCJ366
	ΔgclR::PETaseIs:MHETaseIs ΔpcaIJ	and oCJ367 (2.0 kB).
†Subscript key: E6, Comamonas sp. E6; RHA1, Rhodococcus jostii RHA1; Is, Ideonella sakiensis.

The foregoing discussion and examples have been presented for purposes of illustration and description. The foregoing is not intended to limit the aspects, embodiments, or configurations to the form or forms disclosed herein. In the foregoing Detailed Description for example, various features of the aspects, embodiments, or configurations are grouped together in one or more embodiments, configurations, or aspects for the purpose of streamlining the disclosure. The features of the aspects, embodiments, or configurations, may be combined in alternate aspects, embodiments, or configurations other than those discussed above. This method of disclosure is not to be interpreted as reflecting an intention that the aspects, embodiments, or configurations require more features than are expressly recited in each claim. Rather, as the following claims reflect, inventive aspects lie in less than all features of a single foregoing disclosed embodiment, configuration, or aspect. While certain aspects of conventional technology have been discussed to facilitate disclosure of some embodiments of the present invention, the Applicants in no way disclaim these technical aspects, and it is contemplated that the claimed invention may encompass one or more of the conventional technical aspects discussed herein. Thus, the following claims are hereby incorporated into this Detailed Description, with each claim standing on its own as a separate aspect, embodiment, or configuration.

Claims

1. A genetically modified organism comprising: an exogenous gene addition, wherein:the exogenous gene addition encodes functional enzymes comprising a PETase and a MHETase, andthe genetically modified organism is capable of metabolizing bis(2-hydroxyethyl) terephthalate (BHET) to produce BHET deconstruction products.

2. The genetically modified organism of claim 1, wherein the exogenous gene is from Ideonella sakaiensis.

3. The genetically modified organism of claim 1, wherein the exogenous gene is codon optimized.

4. The genetically modified organism of claim 1, wherein the exogenous gene is incorporated into the genome of the genetically modified organism.

5. The genetically modified organism of claim 1, wherein the exogenous gene addition further comprises genes encoding a secretion signal peptide.

6. The genetically modified organism of claim 1, wherein the genetically modified organism is a species of Pseudomonas.

7. The genetically modified organism of claim 1, wherein the species is Pseudomonas putida.

8. The genetically modified organism of claim 1, wherein the BHET deconstruction products comprise at least one of mono-(2-hydroxyethyl) terephthalate, terephthalate, ethylene glycol, ß-ketoadipate, or muconate.

9. A method comprising contacting poly (ethylene terephthalate) (PET) with the genetically modified organisms of claim 1 to produce PET deconstruction products.

10. The method of claim 9, wherein the contacting is performed in minimal salt medium.

11. A genetically modified organism comprising: an exogenous gene addition, wherein:the exogenous gene addition encodes functional enzymes comprising a PETase and a MHETase, andthe genetically modified organism is capable of metabolizing bis(2-hydroxyethyl) terephthalate (BHET) to produce BHET deconstruction products; andwherein said genetically modified organism further comprises heterologous terephthalic acid (TPA) transporters.

12. The genetically modified organism of claim 11 further comprising catabolic gene clusters I or II.

13. The genetically modified organism of claim 12 wherein the catabolic gene clusters I or II are from Comamonas sp. E6.

14. The genetically modified organism of claim 12 capable of using TPA as a sole carbon source.

15. The genetically modified organism of claim 14 wherein said organism is capable of metabolizing TPA at about 0.05 g L−1 h−1.

16. The genetically modified organism of claim 12 lacking a pcaIJ gene.

17. The genetically modified organism of claim 16 that is capable of metabolizing TPA to ß-ketoadipate.

18. The genetically modified organism of claim 11, wherein the genetically modified organism is a species of Pseudomonas.

19. The genetically modified organism of claim 11, wherein the exogenous gene is from Ideonella sakaiensis.

20. The genetically modified organism of claim 11, wherein the PET deconstruction products comprise at least one of mono-(2-hydroxyethyl) terephthalate, terephthalate, ethylene glycol, ß-ketoadipate, or muconate.